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Lay summary 
How do cells ensure that they have correct amount of DNA (chromosomes) when they divide? 
Cells with an incorrect amount of DNA have catastrophic fates – in humans, Down’s syndrome is 
caused by sperm or egg cells with improper amounts of DNA (an extra copy of chromosome 21). 
Cancer cells also often contain improper amounts of DNA. 
 When a cell divides to form two identical new (daughter) cells, it first duplicates its DNA 
and then partitions this DNA equally between the two daughter cells. If this DNA is not 
partitioned equally, then the daughter cells will contain either too much or too little DNA.  
 Cells have a mechanism called the spindle checkpoint that checks if their DNA going to be 
evenly partitioned; if it looks like there’s going to be a problem with doing this, then the spindle 
checkpoint will not allow cells to divide before the problem is fixed. 
 The spindle checkpoint is a complex piece of cellular mechanism that is difficult to 
understand. To simplify this problem, we have engineered an artificial, stripped-down version of 
it that uses as few components of the mechanism as possible. This approach allows us to better 
understand the contribution of each individual component to the overall workings of the 
mechanism. 
 Importantly, we have discovered that we can make an artificial yet fully functional version of 
the spindle checkpoint by combining only two components togther, one called Spc7 and one 
called Mph1. This shows that these two components of the spindle checkpoint can directly the 
assembly of all the other pieces to make a functional spindle checkpoint. 
Abstract 
The spindle checkpoint ensures proper chromosome segregation by monitoring kinetochore-
microtubule interactions: unattached kinetochores recruit checkpoint proteins that combine to 
form a diffusible inhibitor which delays anaphase, thus buying cells time to fix attachment errors. 
 Although the major checkpoint proteins were identified some 25 years ago, we have only just 
begun to understand how they assemble at unattached kinetochores to generate the crucial 
checkpoint signal. Much of this can be attributed to the difficulty associated with studying these 
proteins at the kinetochores, which are highly complex and thus often make clean dissection of 
function impossible. 
 To circumvent this problem, a synthetic version of the spindle checkpoint was engineered on 
an ectopic location on a chromosome arm away from kinetochores in S. pombe. This work 
describes how the co-targeting of only two checkpoint components, the outer kinetochore 
protein Spc7 and the checkpoint kinase Mph1, was found to be sufficient to successfully generate 
a checkpoint-dependent metaphase arrest and how this paves the way for a clearer, more joined-
up understanding of how the checkpoint works. 
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CHAPTER 1 
Introduction 
1.1    A unified view of checkpoints in the cell cycle 
The cell cycle can be defined as the series of events that cells must undergo in order to reproduce. 
The concept of checkpoints in the cell cycle, where progression to the next step in the cycle is 
dependent on the fulfilment of certain conditions, was first introduced in 1988 by Weinert & 
Hartwell (Weinert and Hartwell, 1988). The description of the DNA damage checkpoint in their 
study encapsulates the checkpoint concept: upon detection of a specific cellular event (DNA 
damage), a negative feedback signal is generated that prevents cell cycle progression (G2 arrest) 
until the checkpoint trigger is removed (DNA damage repaired).  
The discovery of the DNA damage checkpoint came at a time of debate in cell cycle research, 
when two seemingly incompatible views of the cell cycle had emerged. On the one hand, yeast 
genetics groups suggested that the cell cycle was a set of dependent events where later events were 
conditional on the successful completion of preceding events (Lee and Nurse, 1988). In this 
respect the cell cycle was likened to a linear metabolic pathway, with each stage of the cycle 
producing a component that was required for the next stage. This model was thus referred to as 
the ‘product-substrate’ model.  
On the other hand, evidence from embryological studies using eggs and oocytes was used to 
argue that the cell cycle oscillates between mitosis and DNA synthesis irrespective of whether 
either process had been completed. This view came from observations in early embryonic cells 
that the cell cycle continued to progress even though key events such as DNA synthesis were 
inhibited (Dasso and Newport, 1990). Later work showed that neither view was entirely correct 
(Lucchini et al., 1990; McCarroll and Fangman, 1988), and it was not until the discovery of 
checkpoints that the genetic and embryonic evidence was reconciled to produce a unified view of 
the cell cycle. It was later realised that the continued cell cycle progression observed in early 
embryonic cells with incomplete DNA synthesis was not due a lack of checkpoint-enforced 
dependencies, but rather because the checkpoint signals being generated in those cells were too 
weak to prevent progression (Murray and Kirschner, 1989).  
Since the discovery of the DNA damage checkpoint, several other checkpoints have been 
described, including the intra-S checkpoint, triggered by unreplicated DNA, and the spindle 
assembly checkpoint (also known as the mitotic checkpoint, spindle checkpoint or SAC; hereafter 
referred to as the spindle checkpoint), triggered by defects in spindle attachment to 
chromosomes. This latter checkpoint forms the subject of this work. The existence of the spindle 
checkpoint was first hinted at in 1969 by the work of Nicklas and Koch, which showed that insect 
cells possessed an intrinsic ability to correct experimentally-induced errors in chromosome 
alignment (Nicklas and Koch, 1969). This work was the first to observe that chromosomes can 
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somehow sense the level of tension applied to them, and that this was linked to the activation of 
the spindle checkpoint. However, it was not until 1990 that the major components of the spindle 
were identified using genetic screens in yeast (Hoyt et al., 1991; Li and Murray, 1991). Since then, 
work on the spindle checkpoint has focussed on understanding what activates the checkpoint, its 
signal transduction pathways and how it is de-activated (‘silenced’). 
1.2   The spindle checkpoint: summary 
The spindle checkpoint is a conserved eukaryotic mechanism that prevents aneuploidy during 
mitotic and meiotic division. The spindle checkpoint achieves this by monitoring chromosome 
attachments to the spindle microtubules; erroneous attachments or the absence of attachment 
activates the checkpoint and delays entry into anaphase. Once proper attachments have been 
made, the spindle checkpoint is satisfied and subsequently turned off (‘silenced’), allowing cells to 
proceed to anaphase.   
 The spindle checkpoint delays anaphase by inhibiting Cdc20 (Hwang et al., 1998) (S. pombe: 
Slp1 (Kim et al., 1998)), an essential activator of the anaphase promoting complex/cyclosome 
(APC/C). The APC/C is the E3 ubiquitin ligase that signals anaphase entry by targeting securin 
and cyclin B for degradation. In all model organisms the spindle checkpoint proteins involved in 
generating this APC/C inhibitory signal consist of the mitotic arrest defective (Mad) and budding 
uninhibited by benzimidazoles (Bub) proteins (Mad1, Mad2, BUBR1/Mad3, Bub1, Bub3), as well 
as the Mps1 (S. pombe: Mph1) and Aurora B (S. pombe: Ark1) kinases.  
 Until recently the checkpoint signal was held to originate exclusively from unattached 
kinetochores (Rieder et al., 1995), where the various Mad and Bub protein assemble into 
inhibitory complexes before diffusing away to inhibit the APC/C. More recent work shows that 
inhibitory complexes can also be generated at other locations, such as the nuclear pore complexes 
(NPCs) (Rodriguez-Bravo et al., 2014) (see Section 1.5.4).  
1.3   Chapter layout 
This chapter begins by describing how the APC/C is inhibited by the effectors of the spindle 
checkpoint, in particular the MCC. How these effectors are assembled from their constituent 
components will then be described, and the role of Mps1/Mph1 and Aurora B/Ark1 kinases on 
this assembly will be highlighted. The chapter ends with a discussion of how the checkpoint is 
silenced.  
1.4   APC/C inhibitory signals 
The first APC/C inhibitory signal to be described was an ‘activated’ form of Mad2, which was 
found to form a stable complex with Cdc20 (De Antoni et al., 2005). BUBR1 (Mad3 in yeast) was 
subsequently discovered to also exhibit APC/C inhibition (Tang et al., 2001), and it is now clear 
that Mad2 and Mad3/BUBR1 act together as part of a larger inhibitory complex termed the 
mitotic checkpoint complex (MCC). The MCC is comprised of Mad2-Mad3/BUBR1-Bub3-
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Cdc20 in all model organisms except for S. pombe, in which the MCC lacks Bub3. The MCC is a 
far more potent APC/C inhibitor in vitro than either Mad2 or Mad3/BUBR1 alone (Fang, 2002). 
1.4.1  Mad2-Cdc20 
The inhibitory Mad2-Cdc20 complex is formed through what is termed the ‘Mad2 template 
model’. This model arose from the discovery that Mad2 exists in two structurally distinct forms, 
termed open (O-Mad2) and closed (C-Mad2) (De Antoni et al., 2005; Luo et al., 2002). 
Throughout the cell cycle, Mad2 remains bound to its upstream partner Mad1 as part of a highly 
stable, tetrametric (Mad1-C-Mad2)2 complex (hereafter referred to as Mad1-C-Mad2). Upon 
activation of the spindle checkpoint, this Mad1-C-Mad2 complex is directed to unattached 
kinetochores, whereupon the Mad1-bound C-Mad2 becomes capable of dimerising with 
molecules of cytosolic O-Mad2. This dimerisation induces the structural conversation of O-Mad2 
to C-Mad2, which can then bind Cdc20 to form Mad2-C-Cdc20 (Fang et al., 1998; Luo et al., 
2002).  
 Unlike Mad1-bound C-Mad2, which is stably associated, O-Mad2 dimerisation with C-
Mad2 is highly transient, leading to high turnover/cycling of O-Mad2 at unattached kinetochores. 
This difference in the dynamic s of C-Mad2 and O-Mad2 provided key experimental evidence for 
the ‘Mad2-template’ model; studies initially using in vivo (Howell et al., 2004; Shah et al., 2004) 
and later in vitro (Vink et al., 2006) Fluorescence Recovery After Photo-bleaching (FRAP) 
techniques revealed two distinct pools of Mad2: one immobile (Mad1-C-Mad2) and one highly 
dynamic (cycling O-Mad2). At the same time, crystallisation of the Mad1-C-Mad2 complex 
(Musacchio et al., 2002) and the O-Mad2-C-Mad2 dimer (Mapelli et al., 2007) provided 
structural evidence for the model. The C-terminal tail of O-Mad2 was found to undergo a major 
conformational change upon binding of Mad1 or Cdc20, lowering itself over the bound molecule 
to lock it in place. This feature of Mad2 forms the structural basis for the observed stability of the 
Mad1-C-Mad2 and Mad2-C-Cdc20 complexes, and is referred to as the ‘safety-belt’ mechanism 
(Fig. 1.1B, C).  
 Although now universally accepted, open questions remain about the ‘Mad2-template’ 
model. First, it has never been clear whether a newly formed molecule of C-Mad2 binds Cdc20 
immediately following dimerisation, or whether it dissociates from the kinetochore-bound Mad1-
C-Mad2 complex and diffuses away to bind Cdc20 elsewhere. If the latter case is true, it would 
require the existence of a diffusible, transiently un-bound C-Mad2 molecule that is capable of 
binding Cdc20. This hypothetical molecule has never been identified, and is referred to in the 
literature as intermediate Mad2 (I-Mad2) or Mad2*. 
1.4.2  BUBR1/Mad3 and the Mitotic Checkpoint Complex (MCC) 
As noted above, the binding of BUBR1/Mad3 and Mad2 to Cdc20 together produces more potent 
APC/C inhibition in vitro than either does alone (Tang et al., 2001). As its name suggests, BUBR1 
(Bub-related kinase 1) and its yeast homologue Mad3 both share common features with the 
checkpoint protein Bub1, and all three proteins are believed to have evolved from a common 
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Fig. 1.1 – Structures of Mad1 and Mad2 reveals their mode of interaction. (A) Schematic of a Mad1-C-Mad2 
tetrameric complex. The complex comprises of a Mad1 homodimer with two bound molecules of Mad2. The 
N-terminal coiled coils of Mad1 (cyan) mediate Mad1 dimerisation, whilst the C-terminal coiled coils (green) 
are required for kinetochore localisation. The Mad2 binding site of Mad1 lies between these two regions (dark 
blue). Note the contrast between the long, elongated coiled coil structure of Mad1 and the compact globular 
structure of Mad2. (B, C) ‘Safety-belt’ mechanism of Mad2 underlies the stability of the Mad1-C-Mad2 
complex. (B) Unbound Mad2 molecule showing the ‘safety-belt’ (red) and flexible hinge-loop region. Arrow 
indicates conformation change of the ‘safety-belt’ upon Mad1 binding. (C) Mad1-bound Mad2 showing 
‘safety-belt’ closed through conformational change in the flexible hinge-loop induced by Mad1 binding. This 
locks Mad1 and Mad2 together and explains why Mad1-C-Mad2 exists as a highly stable, constitutively 


















ancestor (Vleugel et al., 2012). Features of BUBR1/Mad3 include an N-terminal tetratricopeptide 
repeat (TPR) domain, a Bub3-binding domain (also known as the GLEBS domain), and a C-
terminal kinase domain that is absent in Mad3. Curiously, BUBR1/Mad3 contains a number of 
conserved APC/CCdc20 binding motifs that are normally found on APC/CCdc20 substrates. These 
D(estruction) (RxxLxxxx [EDNQ]) and KEN boxes (KEN) usually mark their bearer for 
ubiquitin-mediated proteolysis, and yet Mad3 is not destroyed in this way. Instead, it has long 
been suspected that the purpose of these APC/CCdc20 binding motifs is to enable BUBR1/Mad3 to 
act as a competitive inhibitor or ‘pseudo-substrate’ for Cdc20 (DeLuca et al., 2011). Indeed, our 
lab was the first to demonstrate that Mad3 requires both of its KEN boxes for checkpoint 
function, and that KEN1 but not KEN2 is required for the incorporation of Mad3 into the MCC 
(King et al., 2007; Sczaniecka et al., 2008).  
Confirmation of the ‘pseudo-substrate’ model arrived with the crystal structure of a partial S. 
pombe MCC comprising of C-Mad2, Cdc20 and a C-terminally truncated Mad3 that lacks KEN2 
(Chao et al., 2012). This structure revealed that Mad3 binds directly to the substrate recognition 
domain of Cdc20 (mediating D- and KEN-box recognition), thus blocking Cdc20 access to 
APC/C substrates (Fig. 1.2A). This mode of binding places Mad3 KEN1 directly on top of the 
KEN-box binding site of Cdc20, thus confirming the finding of our lab that KEN1 is required for 
MCC assembly. Docking of the partial MCC structure into a cryo-electron microscopy model of 
human APC/C (Herzog et al., 2009) revealed a second, previously unknown method of Mad3-
mediated APC/CCdc20 inhibition: MCC-APC/C binding positions Mad3 in such a way that it 
prevents a neighbouring Cdc20 from forming a bi-partite D-box receptor with an APC/C subunit 
(Apc10) (Fig. 1.2B).  
Although revealing, the partial MCC structure left unaddressed the question of Mad3 KEN2 
function, as this was omitted from the structure. Since Mad3 KEN2 is required for checkpoint 
function but not MCC formation, it was speculated (Primorac and Musacchio, 2013) that KEN2 
may be required for the binding of a second molecule of Cdc20. Recent evidence supports this 
idea (Izawa and Pines, 2014). By using a Cdc20 D-box receptor mutant (ΔDR) that allows it to 
form MCC but unable to bind a second Cdc20 molecule, Izawa and colleagues showed that 
together with the D-box, KEN2 of hsBUBR1 mediates the interaction between the MCC and the 
second copy of Cdc20. Moreover, this ΔDR mutant was checkpoint defective, suggesting that 
MCC binding of a second Cdc20 may be required for full checkpoint function.  
1.5   Assembly of checkpoint signalling scaffolds 
Key to our understanding of the spindle checkpoint is how the checkpoint signal is activated and 
propagated in space and time. Over the past decade it has become clear that MCC formation 
involves the assembly of two major complexes or ‘scaffolds’: Mad1-C-Mad2 and 
KNL1/Spc7/Spc105-Bub3-Bub1 (Fig. 1.3). Common to both of these checkpoint scaffolds is the 
importance of checkpoint kinases in their assembly and function. This section thus reviews the 
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Fig. 1.2 – Structure of a partial S. pombe MCC structure reveals two modes of Mad3-mediated APC/C 
inhibition. (A) Mad3 acts as a pseudo-substrate inhibitor of APC/C. Binding of Mad3 (cyan) to Cdc20 
(yellow-green) positions the first Mad3 KEN box (KEN1) directly over the substrate recognisition domain of 
Cdc20, thus denying Cdc20 access to APC/CCdc20 substrates. This explains why KEN1 is required for both 
Mad3 incorporation into the MCC as well as APC/C inhibition. (B) Docking of the partial MCC structure into 
a cryo-electron microscopy model of human APC/C (Herzog et al. 2009) reveals a second, indirect method of 
Mad3-mediated APC/CCdc20 inhibition. The Mad3 of a neighbouring MCC (not shown) binds to the D-box 
binding site (purple), changing the positioning of Cdc20 relative to the various APC/C subunits. This change 
in position leaves Cdc20 unable to form a D-box receptor with the APC/C subunit, Apc10. (C) Positioning of 
partial MCC (circled) within the human APC/C model. Diagrams adapted from (Chao et al. 2012). Cdc20 

































current models for checkpoint scaffold assembly with a particular emphasis on their regulation by 
the Mps1/Mph1 and Aurora B/Ark1 checkpoint kinases. 
1.5.1  Role of Mps1 in the assembly of the KNL1-Spc7-Bub3-Bub1 scaffold 
Mps1 (mono-polar spindle 1) is an essential checkpoint kinase that is found in all model 
organisms except C. elegans, where no homologues have been identified. Mph1 (Mps1 pombe 
homologue 1) differs from Mps1 in that its functions are more limited; whereas Mps1 is involved 
in spindle pole body (SPB) duplication, bi-orientation and the spindle checkpoint, the role of 
Mph1 is largely confined to bi-orientation and the spindle checkpoint (He et al., 1998; Zich and 
Hardwick, 2010). Overexpression of Mps1/Mph1 induces checkpoint-mediated metaphase arrest 
(Hardwick et al., 1996; He et al., 1998; Ito et al., 2012), whilst inhibition of Mps1 abolishes both 
the kinetochore localisation of all other checkpoint components as well as checkpoint function 
(Maciejowski et al., 2010; Sliedrecht et al., 2010; Vigneron et al., 2004).  
 Recent work shows that together with Aurora B/Ark1, Mps1/Mph1 is the most upstream 
component of the checkpoint signalling pathway. In S. pombe, the removal of almost all other 
checkpoint components from the kinetochores does not abolish checkpoint function, as long as 
Mph1 remains at the kinetochores (Vanoosthuyse et al., 2009). Forced targeting of Mps1/Mph1 
to the kinetochores of Ptk2 (rat-kangaroo epithelial kidney) cells (Jelluma et al., 2010) and S. 
pombe (Ito et al., 2012) results in constitutive checkpoint activation (for caveats, see Chapter 3). 
Lastly, it has been demonstrated that in human-derived cells, Mps1 acts as a key activation trigger 
for the checkpoint by competing with microtubules at kinetochores (Hiruma et al., 2015; Ji et al., 
2015). In light of its central role in checkpoint activation, it is perhaps not surprising that 
Mps1/Mph1 is involved in the assembly of both Mad1-C-Mad2 as well as KNL1/Spc7/Spc105-
Bub3-Bub1 scaffolds.  
 Mps1/Mph1 activity is required for the localisation of Bub1 to unattached kinetochores, but 
only recently has the underlying mechanism become clear. Together with the Biggins lab, our lab 
in collaboration with J. Millar was the first to identify an outer kinetochore component, Spc7 (S. 
cerevisiae: Spc105; vertebrates: KNL1), as the key Mph1 target that enables Bub1 localisation to 
unattached kinetochores (London et al., 2012; Shepperd et al., 2012). KNL1 (kinetochore null 1) 
was originally identified as an essential kinetochore assembly component in C. elegans (Desai et 
al., 2003), and has since been recognised as a component of the conserved microtubule (MT)-
binding KMN (KNL1/Mis12/Ndc80) outer kinetochore complex (Varma and Salmon, 2012). The 
function of KNL1 and its homologues is now known to extend beyond microtubule binding and 
include serving as a binding platform for spindle checkpoint components and protein 
phosphatases. Using in vitro kinase assays and in vivo imaging, our lab showed that the Mph1-
dependent phosphorylation of Spc7 along a series of conserved MELT motifs 
([M/I][E/D/N][I/L/M][S/T]) enables it to bind Bub1 in a Bub3-dependent manner (Shepperd et 
al., 2012). The Watanabe lab shortly afterwards reported similar findings which, despite some 
disagreement over the exact number of phosphorylated MELTs required for Bub1 recruitment, 
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confirmed the importance of our findings as well as their conservation in human-derived cells 
(Yamagishi et al., 2012) (Fig. 1.4A). 
 Nevertheless how Bub1 localised to kinetochores via phosphorylated KNL1/Spc7 remained 
unclear: did it directly interact with phospho-MELTs, or did it do so via Bub3? Attention initially 
focussed on the conserved N-terminal TPR domain of Bub1, as this domain interacts directly 
with KNL1 via the latter’s KI motifs, a feature that is not present in KNL1’s homologues in yeast 
(Kiyomitsu et al., 2007, 2011). These studies demonstrated that mutations in the hsBub1 TPR 
domain not only abolished its interaction with KNL1 but also interfered with downstream 
checkpoint signalling. Taken together with the finding that KNL1 depletion abolishes both 
hsBub1 kinetochore localisation and checkpoint function, these results lead Kiyomitsu and 
colleagues to conclude that Bub1 localises to kinetochores via interaction between its TPR 
domain and KNL1. This propensity of KNL1 to bind Bub proteins lead these authors to propose 
that hsKNL1 be renamed Blinkin (Bub-linking kinetochore protein).  
 This hypothesis was refuted when the crystal structures of the Bub1-KNL1 and BUBR1-
KNL1 complexes were solved, revealing residues that when mutated would abolish Bub1/BUBR1 
interaction with KNL1 whilst leaving their kinetochore localisation intact (Krenn et al., 2012). In 
contrast, mutation of the Bub3-binding site of Bub1/BubR1 abolished kinetochore localisation, 
thus demonstrating that Bub1 localisation to the kinetochores occurs indirectly via Bub3-KNL1 
interaction (Fig. 1.4B). Once Bub3 is bound to phosphorylated KNL1, Bub1 serves to stabilise the 
Bub3-KNL1 interaction (Krenn et al., 2012; Primorac et al., 2013). 
 This leaves the question of how Mad3/BUBR1 is localised to kinetochores. As previously 
mentioned, BUBR1 exhibits significant homology with Bub1 and contains an N-terminal TPR 
domain that interacts with KNL1. As with Bub1, this interaction was found to be largely 
dispensable for the kinetochore localisation of BUBR1 (Krenn et al., 2012), leading to suggestions 
that BUBR1 might localise to the kinetochores indirectly via Bub3, since both Bub1 and BUBR1 
form constitutive complexes with Bub3. Surprisingly however, BUBR1 was found to be unable to 
stabilise the Bub3-KNL1 interaction (Krenn et al., 2012; Primorac et al., 2013), thus detracting 
from the Bub3-mediated model. Instead, recent evidence suggests that at least in humans, BUBR1 
localises to kinetochores directly via Bub1 binding (Overlack et al., 2015); whether this model 
involves dynamically cycling BUBR1, and whether it extends to yeast Mad3/Bub1 recruitment 
remain to be seen.  
1.5.2  Role of Mps1 in the assembly of the Mad1-Mad2 scaffold 
Mps1/Mph1 has been implicated in regulating both Mad1-C-Mad2 complex formation at the 
kinetochores as well as the subsequent catalysis of O-Mad2 dimerisation. Much of the current 
evidence for this regulation is indirect, however, making this key process poorly understood. In 
human-derived cells, it has been suggested that Mps1 has multiple roles in mediating Mad1-
Mad2 recruitment to the kinetochores, and that Mad1 is a possible substrate for these roles 
(Hewitt et al., 2010). Through the use of small-molecule Mps1 inhibitors, Hewitt and colleagues 
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observed that inhibition of Mps1 prior to mitotic entry abolishes kinetochore recruitment of 
Mad1-C-Mad2, whereas Mps1 inhibition after mitotic entry does not evict Mad1-C-Mad2 from 
kinetochores but instead prevents O-Mad2 dimerisation. These results were interpreted to 
suggest that Mps1 activity is first required for the initial localisation of Mad1-C-Mad2 to the 
kinetochore, after which it is required to maintain recruitment of O-Mad2 to Mad1-C-Mad2. 
Although this model is attractive, it remains speculative because Mad1 has not been confirmed as 
an Mps1 target, and Mad1 phosphorylation sites have yet to be mutated and studied.  
Similarly indirect evidence for Mps1-mediated phospho-regulation of Mad1 exists in yeast. 
In S. cerevisiae, Ndc80 has been implicated as an Mps1 target in vitro (Kemmler et al., 2009). 
Phospho-analysis by Kemmler and colleagues showed that a non-phosphorylable (alanine) form 
of Ndc80 rendered the checkpoint inactive, whilst a phosphomimetic mutant restored some, but 
not all, checkpoint function to a strain depleted of Mps1. This latter result is important as it 
implies that Mps1-mediated phosphorylation of other substrates is required for full checkpoint 
function. Again, Mad1 is a strong candidate for this role, and phospho-analysis of Mad1 will 
likely yield important information on Mad1-C-Mad2 interaction. It is however important to note 
here that the Biggins lab were unable to reproduce the results of Kemmler and colleagues .  
Unlike the case for Mad1, evidence for Mps1/Mph1-mediated phospho-regulation of Mad2 
has been more direct. In S. pombe, our lab has identified several in vitro phosphorylation sites on 
Mad2 that are important for regulating MCC-APC/C interaction, as well as possibly Mad1-C-
Mad2 complex formation (Zich et al., 2012). Whereas current evidence suggests that Mps1 
phosphorylation of Mad1 positively regulates checkpoint function, Zich and colleagues found 
that a phosphomimetic form of a Mph1 target on Mad2 actually negatively regulates checkpoint 
function, a surprising result that mirrors those previously obtained in human-derived cells 
(Wassmann et al., 2003). These results imply a novel checkpoint silencing function for Mps1 that 
is seemingly at odds with the current consensus that Mps1 is a positive checkpoint regulator, and 
further work is required to confirm these findings and reconcile them with the currently available 
Mps1 evidence.  
1.5.3  The mutual dependencies between Spc7/KNL1-Bub3-Bub1 and Mad1-C-Mad2 
Although the previous two sections have described the assembly of the Spc7/KNL1-Bub3-Bub1 
and Mad1-C-Mad2 scaffolds as independent processes, recent evidence suggests that they may 
directly interact through Mad1-Bub1 interaction. This interaction was first hinted at by the 
finding of our lab that in S. cerevisae, Mad1 can co-immunoprecipitate with the Bub1-Bub3 
complex during mitosis (Brady and Hardwick, 2000). This co-immunoprecipitation was also 
observed in nocodazole treated (checkpoint arrested) but not in interphasic cells, suggesting that 
the Mad1-Bub1-Bub3 interaction is checkpoint-specific. A direct Mad1-Bub1 interaction was 
recently confirmed by London  and colleagues (London and Biggins, 2014a), demonstrating that 
in S. cerevisae, a central fragment of Bub1 is capable of recruiting Mad1 to kinetochores upon 
phosphorylation by Mps1. Moreover, by building on their earlier finding that Mps1-mediated 
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phosphorylation of Spc105 is sufficient for Bub1 recruitment (London et al., 2012), the authors 
demonstrated that Mps1 directs the assembly of a combined Spc105-Bub1-Mad1 scaffold in the 
following manner. First, Spc105 is phosphorylated along its MELT motifs by Mps1, which enables 
it to recruit the Bub3-Bub1 complex. Phosphorylation of Bub1 at specific residues identified in 
(London and Biggins, 2014a) then enables it to bind Mad1 and therefore Mad2. By showing that 
Mps1 regulates both Bub1-Mad1 interaction as well as Spc105-Bub1 interaction, these results 
again highlight the central importance of Mps1/Mph1 in directing checkpoint activation.   
 Although this unified model of checkpoint scaffold assembly at kinetochores is attractive, it 
is unclear if it extends beyond S. cerevisiae. In C. elegans, although a Mad1-Bub1 interaction at 
the kinetochores has been recently reported (Moyle et al., 2014), it is likely regulated in a different 
manner from the Mad1-Bub1 complex of S. cerevisae as no Mps1 homologues are known to exist 
in C. elegans. In mammalian systems, conflicting evidence exists on Mad1-Bub1 interaction: 
although a previous study found that phosphorylated hsMad1 interacts with hsBub1 (Seeley et al., 
1999), a more recent study was unable to reproduce this interaction despite reporting more 
evidence implying its existence (Kim et al., 2012). Specifically, this latter study showed that 
mutation of an RLK motif on hsMad1 (originally identified in S. cerevisae as being critical for 
Mad1-Bub1 interaction (Brady and Hardwick, 2000)) abolished the kinetochore localisation of 
hsMad1. This was taken as evidence of hsMad1-hsBub1 interaction, but as efforts to detect a 
physical interaction proved fruitless, the authors could at best conclude that such an interaction is 
likely highly transient (Kim et al., 2012). No Mad1-Bub1 interaction has yet been reported in S. 
pombe, but it remains an intriguing possibility in light of recent genetic evidence that Bub1 is 
required for Mad1 localisation to kinetochores (Heinrich et al., 2012).  
1.5.4  Are checkpoint components needed at kinetochores? 
Although the assembly of checkpoint scaffolds at the kinetochores is now better understood, how 
this co-localisation of the checkpoint components at the kinetochores produces rapid, global and 
reversible APC/C inhibition remains the sought-after ‘holy grail’ of checkpoint research. Is the 
enrichment of checkpoint components the sole function of kinetochore localisation? Related to 
this, do all of the checkpoint components need to localise to the kinetochores to function? Our 
lab has previously shown that, uniquely in S. pombe, deletion of bub3 abolishes the detectable 
enrichment of almost all checkpoint proteins (Mad1, Mad2, Mad3, Bub1) from kinetochores, and 
yet the checkpoint remains functional (Tange and Niwa, 2008; Vanoosthuyse et al., 2009; 
Windecker et al., 2009). Similarly, depletion of Hec1 (Ndc80) in human-derived cells evicts both 
Mps1 and the Mad1-C-Mad2 complex from the kinetochores without impairing checkpoint 
function (Martin-Lluesma et al., 2002).  
 These results indicate that checkpoint signalling can be initiated and propagated away from 
the kinetochores. Strongly supporting this idea is the recent finding in human-derived cells that 
nuclear pore complexes (NPCs) can function as a scaffold for checkpoint signalling, and that this 
generates APC/C inhibitors just before mitosis (Rodriguez-Bravo et al., 2014). Although it has 
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long been known that Mad1-C-Mad2 localises to the nuclear periphery during interphase, by 
demonstrating that this can generate APC/C inhibitors the authors presented an intriguing model 
whereby two distinct checkpoint scaffolds are required for rapid and global APC/C inhibition. An 
important implication of this model that was not directly tested by the authors is that because the 
KNL1-Bub3-Bub1 scaffold has not been reported to associate with NPCs, checkpoint signal 
generation at the NPCs likely follows a different assembly process than that at kinetochores. 
 The idea that the kinetochore localisation of checkpoint components is somehow essential 
for checkpoint signal generation is further challenged by the fact that Mad3/BUBR1 localisation 
to kinetochores is absent in S. cerevisiae (Gillett et al., 2004) and C. elegans (Essex et al., 2008), 
and may also not be required for checkpoint function in human-derived cells (London and 
Biggins, 2014b). As mentioned above, although Mad3 does localise to S. pombe kinetochores 
upon checkpoint activation, its eviction from the kinetochores does not abolish checkpoint 
function (Vanoosthuyse et al., 2009) and it will be important to determine if it can be 
incorporated into MCC complexes away from the kinetochores.  
1.6   Tension sensing with Aurora B kinase 
As mentioned above, the spindle checkpoint functions by monitoring attachment between the 
spindle microtubules and the kinetochore. Using vertebrate cells, Rieder and colleagues showed 
that a single unattached kinetochore is sufficient to activate the spindle checkpoint (Rieder et al., 
1995). Improper microtubule-kinetochore attachments, such as when both sister chromosomes 
attach to the same pole (syntelic attachment), also activates the spindle checkpoint (Watanabe, 
2012). 
What is not clear is the molecular mechanism by which the spindle checkpoint detects 
improper kinetochore attachments. The most favoured model remains the ‘tension-sensing’ 
model (for review see (Lampson and Cheeseman, 2011)), which postulates that Aurora B kinase 
(S. pombe: Ark1) functions as a ‘kinetochore stretch sensor’. Aurora B is a kinase that is part of 
the chromosome passenger complex (CPC), consisting of Aurora B, Survivin, Borealin and the 
inner centromere protein (INCENP). The CPC is positioned at the centre between two sister 
kinetochores (also known as the inner centromere). It is believed that when proper (bi-polar) 
attachment occurs, the opposing forces exerted on the two sister kinetochores pulls them apart, 
thus moving them farther apart from Aurora B at the centre. This in turn reduces the level of 
phosphorylation of Aurora B substrates, including the outer kinetochore protein Ndc80. The 
phosphorylation of Ndc80 by Aurora B weakens and ultimately breaks kinetochore-microtubule 
attachments. This in turn results in unattached kinetochores, which then triggers the spindle 
checkpoint.  
This Aurora B-dependent ‘tension-sensing’ model is thus a spatial model that is based on 
two key observations. First, it was shown that the phosphorylation levels of a given Aurora B 
substrate are inversely proportional to the distance between Aurora B and that substrate (Liu et 
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al., 2009). Second, if Aurora B is experimentally moved from the inner centromere to the outer 
centromere, then Aurora B substrates become constitutively phosphorylated, and it becomes 
impossible to stabilise kinetochore-microtubule attachments.  
The ‘tension-sensing’ model is at present the most attractive answer to the question of how 
the spindle checkpoint can detect and thus respond to improper chromosome attachments; it 
explains how properly attached (under tension) and improperly attached (no tension) 
chromosomes can be distinguished. However, it is increasingly clear that the tension-sensing 
model requires revision to accommodate recent findings. It was recently shown in human cells 
that a significant pool of Aurora B kinase is found at the outer kinetochore, even after Hec1 
(vertebrate homologue of Ndc80) is dephosphorylated (DeLuca et al., 2011). This suggests that 
the phosphorylation of Hec1 is not entirely regulated by the spatial positioning of Aurora B. One 
possible explanation is that there are multiple ways by which Aurora B activity is regulated, 
although no experimental evidence for this currently exists. It will be interesting to see if these 
observations are also true for Ark1 and Ndc80.  
1.7   Checkpoint silencing 
1.7.1  Silencing inactivates the spindle checkpoint 
Once proper microtubule-kinetochore attachments have been established, the spindle checkpoint 
is satisfied and signalling must be inactivated in order to allow cells to proceed to anaphase. This 
is known as checkpoint silencing, which encompasses a range of different mechanisms with 
varying degrees of conservation and experimental evidence. When proper microtubule-
kinetochore attachments are made and checkpoint silencing is initiated, active APC/C inhibitors 
are both present in the cytoplasm as well at the kinetochores where they are generated. Thus, in 
order to effect silencing the cell must (i) stop further APC/C inhibitor generation at the 
kinetochores, and (ii) quench the active APC/C inhibitors in the cytoplasm.  
1.7.2  Silencing mechanisms 
The most conserved silencing mechanism is mediated by PP1 phosphatase (Protein phosphatase 
1; S. pombe: Dis2). At the kinetochores, KNL1/Spc7 acts in conjunction with the kinesins Klp5/6 
to mediate the recruitment of PP1/Dis2 (Liu et al., 2010). Once at the kinetochores, PP1Dis2 
phosphatase activity opposes kinetochore-localised Aurora B kinase acting to destabilise 
microtubule-kinetochore attachments. When the kinetochore is not under tension (stretched), 
Aurora B targets KNL1, rendering it unable to recruit PP1. Once proper attachments have been 
made, kinetochore stretch acts to distance KNL1 from Aurora B, thus relieving the inhibitory 
phosphorylation on KNL1 (Liu et al., 2010). This enables the recruitment of PP1 to the 
kinetochores, whereupon the stabilising effect of PP1 on attachments ensures further recruitment 
of PP1 in a positive-feedback loop. Thus, the end effect of PP1-mediated silencing is the reversal 
of checkpoint kinase activity at the kinetochores. Key PP1 substrates remain to be identified.  
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Another silencing mechanism that has been proposed to remove the APC/C inhibitors being 
generated at the kinetochore is dynein-dependent ‘stripping’ of Mad2. Unlike PP1-mediated 
silencing, this ‘stripping’ mechanism is likely neither essential nor conserved. Upon proper 
microtubule-kinetochore attachment, Mad1 and Mad2 are transported along the spindle fibres 
from unattached kinetochores to the spindle pole bodies (SPBs) by the dynein/dynactin 
microtubule motor complex (Gassmann et al., 2010; Howell et al., 2001). Detracting from the 
importance of ‘stripping’ however is the observation that depletion of Spindly, a kinetochore 
component required for the dynein binding, does not completely abolish poleward Mad1/Mad2 
transport in HeLa cells (Gassmann et al., 2010). This is currently no evidence for ‘stripping’-
mediated silencing in yeast.  
Vertebrates have a unique silencing mechanism in the form of p31comet, a competitive 
inhibitor of Mad2 (no p31comet homologues have been reported in yeast). The structure of p31comet 
was found to closely resemble that of Mad2, enabling it to bind or ‘cap’ Mad2 within the Mad1-C-
Mad2 complex (Xia et al., 2004; Yang et al., 2007). Thus, p31comet has been proposed to mediate 
silencing through preventing the dimerisation and subsequent activation of soluble O-Mad2. 
However, although it is accepted that p31comet is an important silencing mechanism in vertebrates 
because its depletion constitutively activates the checkpoint while its overexpression overrides it 
(Habu et al., 2002), exactly where this silencing occurs remains controversial. p31comet localises to 
kinetochores, where it was originally proposed to ‘cap’ kinetochore bound Mad1-C-Mad2. 
However, using an antibody that preferentially binds O-Mad2, Westhorpe and colleagues found 
that p31comet localisation to the kinetochore did not affect the amount of O-Mad2 localised at 
kinetochores, even upon p31comet overexpression (Westhorpe et al., 2011). This suggests that 
p31comet effects silencing downstream of kinetochores, and the authors propose a model in which 
p31comet binding to MCC via Mad2 promotes MCC disassembly. Like many such attractive 
models, current evidence for p31comet-mediated MCC disassembly is largely indirect and more 
work will be required for its acceptance.  
1.8   Aims of this work 
This work aims to achieve the following two goals: 
1. A better understanding of Mad1-Mad2 interaction. The evidence reviewed above 
indicate that certain aspects of the regulation of Mad1-Mad2 interaction remain poorly 
understood. Chapter 3 will thus first examine the role of the N-terminus of Mad1 in 
mediating Mad1-C-Mad2 interaction. Then, the phospho-regulation of Mad1 will be 
examined using a series of Mad1 phospho-mutants created based on mass spectrometry 
data.  
2. Determine whether the role of kinetochores in spindle checkpoint signalling is solely 
to enrich for checkpoint components. Since the discovery that unattached kinetochores 
are one of the major sources of the spindle checkpoint signal, this is arguably one of the 
biggest unresolved questions of checkpoint signalling. This important issue forms the 
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recurring theme for this entire work, but is most directly addressed in Chapters 4 and 5 
where the enrichment of checkpoint components away from the kinetochores will be 
tested to determine if they are able to generate a ‘synthetic’ checkpoint signal that is 




Materials & Methods 
2.1 DNA methods 
2.1.1 Polymerase chain reaction  
For cloning work, Phusion® or Q5® High-Fidelity 2X Master Mix (New England Biolabs) was used 
in accordance with the manufacturer’s instructions. PCR products were visualised by agarose gel 
electrophoresis using ethidium bromide.  
2.1.2 Gateway® cloning 
All Gateway®-based cloning was performed using kits (LR Clonase II Enzyme Mix, BP Clonase II 
Enzyme Mix) obtained from Invitrogen (Section 2.4) in accordance with the manufacturer’s 
instructions, except that all volumes indicated in the instructions were halved to give a final 
volume of 5 µl/reaction. 
2.1.3 Site directed mutagenesis 
All site-directed mutagenesis was performed using the Quikchange® II or Quikchange® Lightning 
site-directed mutagenesis kits (Strategene) (Section 2.4) in accordance with the manufacturer’s 
instructions, except that all volumes indicated in the instructions were scaled-down by 5x to 
give a final volume of 10 µl/reaction.  
2.1.4 Sequencing 
Sanger sequencing was carried out by Genepool (University of Edinburgh) on samples processed 
with BigDye® v3.1 Cycle Sequencing Kit (Applied Biosystems). BigDye® reactions were performed 
in accordance with the manufacturer’s instructions.  
2.1.5 Restriction endonuclease digestion 
All restriction enzymes were obtained from New England Biolabs or Roche and used in 
accordance with the manufacturer’s instructions.  
2.1.6 De-Phosphorylation 
Linearised vectors were treated with Antarctic Phosphatase (New England Biolabs) in accordance 
with the manufacturer’s instructions.  
2.1.7 Ligation 
Ligations were performed using T4 Quick Ligase (New England Biolabs) in accordance with the 
manufacturer’s instructions before transformation into E. coli (Section 2.1.8). 
2.1.8 Bacterial transformation 
Transforming DNA was added to de-frosted chemically-competent E. coil cells in a pre-chilled 
screw-cap tube. Following gentle mixing, the mix was incubated on wet ice for 30 min. before 
being subjected to heat shock at 42 oC in a water bath for 45 s. 200-900 µl of pre-warmed SOC 
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medium was then added and cells were allowed to recover for 1 hour at 37 oC with shaking before 
plating unto selective plates.  
2.1.9 Yeast transformation 
Both lithium acetate and electroporation were used for yeast transformation. It should be noted 
that some constructs exhibited greater transformation efficiency using one method than the 
other, and thus the optimal method for a given construct should be determined empirically. 
For electroporation, cells were grown to mid-exponential phase (OD600 = 0.5) in YES (Section 
2.5.1) before harvesting (1701 x g, 2 min 30 s) and transferred to a pre-chilled microfuge tube and 
placed on wet ice. Cells were washed once with ice-cold water and once with ice-cold 1 M 
sorbitol. Following the sorbitol wash cells were re-suspended in ice-cold sorbitol to a final density 
of 1 x 109 cell/ml. 40 µl of the cell suspension was transferred to a pre-chilled microfuge tube 
containing 10 µl of transforming DNA (~1.5 µg) and mixed. The mixture was then transferred to 
a pre-chilled cuvette (0.2 cm gap) and incubated for 5 min. on wet ice before being electroporated 
at 1.8 kV, 200 Ω, 25 µF capacitance using a BioRad electroporator. After electroporation 500 µl of 
ice-cold sorbitol was immediately added to the cuvette before the entire mix was transferred to a 
clean microfuge tube. Transformed cells were harvested (1701 x g, 2 min) and depending on the 
type of selection either plated unto selective plates or being allowed to recover in YES at 30 oC 
with shaking overnight before plating.  
 For lithium acetate transformation (Ito et al., 1983), exponentially growing cells were 
obtained as described above, and after harvesting (1701 x g, 2 min 30 s) cells were washed once 
with 25 ml of water before being resuspended in 1 ml of water. 1 x 108 cells were then aliquoted 
for each transformation. After spinning (1701 x g, 2 min 30 s) to remove the water, cells were 
incubated in 100 mM lithium acetate buffer (0.1 M lithium acetate pH 4.9) at 30 oC for 30 min. 
before pelleting and resuspension in a transformation mix consisting of 290 µl of PEG buffer (50 
% w/v polyethylene glycol 3350, 0.1 M lithium acetate pH 4.9) and ~2 µg of transforming DNA. 
This mix was then incubated at 30 oC for 60 min., before being subjected to heat shock at 42 oC 
for 15 min. Transformed cells were harvested (1701 x g, 2 min) and depending on the type of 
selection either plated unto selective plates or being allowed to recover in YES at 30 oC with 
shaking overnight before plating.  
2.1.10 Yeast genomic DNA extraction 
Yeast genomic DNA for cloning and for diagnostic PCR was obtained using the single-tube 
LiOAc-SDS lysis method described in (Lõoke et al., 2011).  
2.1.11 Ethanol precipitation of DNA 
To precipitate DNA from aqueous solutions, three volumes of ice-cold 96 % ethanol and 1/10 
volume 3 M sodium acetate solution was first added to one volume of DNA solution in a 
microfuge tube. After incubating on wet ice for 15-30 min., tubes were centrifuged at maximum 
speed at 4 oC for 10 min. before the supernatant was removed and a wash of 500 µl 70 % ethanol 
solution applied. Without mixing, the tubes were re-spun at maximum speed at 4 oC for 5 min. 
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After removing the wash solution, tubes were air-dried for 5 min. before the pellet was 
resuspended in TE buffer.  
2.2 Protein methods 
2.2.1 Yeast protein lysis buffer 
The ‘CLAAPE’ protease inhibitor mix indicated with an asterisk (*) is composed of the following 
protease inhibitors: chymostatin, leupeptin, aprotinin, antipain, pepstatin and E-64, all dissolved 
in DMSO at a final concentration of 10 mg/ml each. 
Component Final conc.  
HEPES, pH 7.6 50 mM 
KCl 75 mM 
MgCl2 1 mM 
EGTA 1 mM 
TX-100 0.1 % 
NaVO4 1 mM 
CLAAPE mix*  
PMSF 1 mM 
 
2.2.2 Yeast protein extracts 
10-25 ml of cells were grown overnight in the appropriate medium (30 oC, 250 RPM) before being 
harvested (1701 x g, 2 min 30 s) and transferred to a screw-cap tube. A wash with 1 ml of ice-cold 
water was then applied before cell pellet sizes were normalised and mixed with 100 µl of lysis 
buffer (Section 2.2.1) and an equal quantity of silica beads. Cells were broken by bead-beating (2 x 
20 s, 1 min. on ice in between) before 100 µl of 2x sample buffer was added. After brief vortexing, 
extracts were denatured at 95 oC for 5 min. before cell debris was pelleted by centrifugation 
(10,621 x g, 5 min., 4 oC). Cleared cell extracts were then immediately loaded onto SDS-PAGE 
gels (Section 2.2.4).  
2.2.3 Co-immunoprecipitation with GFP-Trap® 
For pull-down of GFP-tagged proteins, magnetic GFP-Trap®_M beads (Chromotek) was used in 
accordance with the manufacturer’s instructions with the following modifications: 3 µl of beads 
were typically used per reaction; cells lysed at 4 oC using a Ribolyser (Hybaid) for 2 x 20s at force 
setting 4.5 with chilling on ice in between each round of lysis. Samples were then separated using 
SDS-PAGE. 
2.2.4 SDS-PAGE 
Resolving gels were made according to the following recipe: 
 10.0 % 12.5 % 15.0 % 
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40 % acrylamide 3.7 ml 4.7 ml 5.6 ml 
2 % Bis 0.98 ml 0.75 ml 0.64 ml 
1.5 M Tris-HCl pH 8.8 3.75 ml 
Water to 15 ml 
 
150 µl 10 % ammonium persulfate (APS) and 15 µl TEMED was added immediately prior to use. 
Resolving gels were overlaid with butan-1-ol and allowed to set before the alcohol was removed 
and stacking gel added: 
40 % acrylamide 6.25 ml 
2 % Bis 3.33 ml 
1.0 M Tris-HCl pH 6.8 6.25 ml 
Water to 50 ml 
 
Proteins were typically resolved on 10 cm x 20 cm SDS-PAGE gels for 90 min at a constant 
voltage of 120-160 V in SDS-PAGE buffer (50 mM Tris, 384 mM glycine, 2 % SDS).  
 Following resolution, proteins were transferred unto nitrocellulose membranes (GE 
Healthcare) using a TE77 semi-dry transfer unit (Hoefer) at 125 mA for 90 min in semi-dry 
transfer buffer (25 mM Tris, 130 mM glycine, 20 % methanol).  
2.2.5 Immunoblot 
Membranes were blocked in blocking solution (1x PBS, 0.04 % Tween 20, 4 % w/v dried skimmed 
milk (Marvel)) for 40 min. at room temperature before incubation overnight in primary antibody 
at 4 oC. Membranes were then washed with PBS + 0.04 % Tween 4 times for 5 min. each before 
the appropriate secondary antibody was applied for 40 min at room temperature. A further 4 
washes of PBS + 0.04 % Tween was applied to remove unbound antibody before protein 
visualisation.  
2.2.6 Protein visualisation 
Proteins were visualised by chemiluminescence using an ECL detection kit (SuperSignal West 
Pico or SuperSignal West Femto, Pierce) according to the manufacturer’s instructions. 
Membranes were overlaid with clear acetate sheets before being exposed to X-ray film (Agfa 
Healthcare). Films were subsequently developed using a SRX-101A Film Processor (Konica-
Minolta).  
2.2.7 Antibodies used in this work 
HRP-conjugated secondary antibodies are indicated with an asterisk (*).   
Antibody Species Conc. Source 
Anti-GFP Sheep 1:1000 Hardwick lab 
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Anti-tubulin (TAT1) Mouse 1:1000 Gift from Keith Gull 
Anti-Mph1 Sheep T 1:1000 Hardwick lab 
Anti-FLAG M2 Mouse 1:1000 Sigma-Aldrich 
Anti-Mad2 Sheep 1:1000 Hardwick lab 
Anti-sheep, HRP conjugated* Donkey 1:5000 Jackson Immuno-Research 
Anti-mouse, HRP conjugated* Donkey 1:5000 GE Healthcare 
Anti-rabbit, HRP conjugated* Sheep 1;5000 GE Healthcare 
 
2.3 Yeast methods 
2.3.1 Anhydrotetracycline 
Addition of anhydroxytetracycline (aTc) to yeast medium at a final concentration of 10 µM 
enables binding of rTetR to tetO sequences. A concentrated (1000x) stock of 10 mM was prepared 
in DMSO and filter-sterilised prior to storage at -20 oC.  
2.3.2 Wide-field epi-fluorescence microscopy 
All fluorescence microscopy experiments except those for FRAP were performed using a Zeiss 
Axiovert 200M inverted epi-fluorescent microscope (Carl Zeiss Ltd.) equipped with a 100x 1.49 
N.A. objective lens and a CoolSnap CCD camera (Photometrics). Images were acquired and 
analysed using Slidebook 5.5 software (Intelligent Imaging Innovations Inc.). Acquisition settings 
were as follows: 300 ms exposure (FITC & CY3), 2x binning, Z-series over 3 µm range in 0.5 µm 
steps (7 planes). Maximum projection images were created using Slidebook. Cell culture 
conditions for FRAP, tethering and synthetic signalling assays are described in their own sections 
in this chapter.  
2.3.3 Fluorescence recovery after photobleaching (FRAP) 
All FRAP experiments were performed using a spinning disk confocal microscope comprising of 
a Nikon TE2000 inverted microscope with a Nikon 100x/1.45 NA Plan Apo objective, attached to 
a modified Yokogawa CSU-10 unit (Visitech) and an Andor iXon+ Du888 EMCCD camera, 
controlled by Metamorph software (Molecular Devices). The microscope was fitted with a 
temperature controlled chamber which was set at 25 oC for all experiments. Typical acquisition 
settings were as follows: 100 ms exposure, 2x binning, Z-series over 3 µm range in 0.5 µm steps (7 
planes).  
 Cells for FRAP were grown and prepared as follows. Exponentially growing cells were 
obtained by growth in liquid PMG medium (no aTc, with thiamine) at 30 oC with shaking for 6-8 
hours before diluting down in PMG medium (with aTc, no thiamine) for 12-20 hours until an 
OD600 of 0.5 was reached. Cells were washed in clear PMG medium (Section 2.5.2) (no aTc, no 
thiamine) before mounting onto lectin-coated 35 mm glass-bottomed dishes (Part no.: P35G-1.5-
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20-C, MatTek) using the procedure below. Mounting of cells unto glass-bottom dishes in this way 
greatly reduces cell stress and allows them to be imaged for much longer periods of time.  
 20 µl of 1 mg/ml filter-sterilised lectin solution (Part no.: L1395-5MG, Sigma-Aldrich) was 
spread unto a 35 mm glass-bottomed dish using a sterilised bent glass pasteur pipette and 
incubated for 10 min. at 25 oC. To prevent scratches to the glass (coverslip) bottom, dishes were 
kept in a clean petri-dish throughout the mounting procedure. Excess lectin solution was then 
gently removed using five washes of 1 ml sterile water and two washes of 1 ml clear PMG 
medium (no aTc, no thiamine). It is imperative that all washes be done gently by slowly 
pipetting liquid unto one side of the glass bottom whilst simultaneously aspirating from the 
opposite side; excessively harsh washing reduces both the strength and uniformity of cell 
adhesion across the coverslip. Following washing approx. 0.2 OD600 units of cells (1 ml of OD600 = 
0.5 cells equals 0.5 OD600 units) were gently added to the glass bottom and allowed to adhere for 
20 min. at 25 oC. Dishes were left undisturbed throughout this time. Unbound cells were then 
gently removed using five washes of clear PMG (no aTc, no thiamine) before 400 µl of clear PMG 
(no aTc, no thiamine) was added. Cells were imaged immediately in a temperature controlled 
chamber pre-heated to 25 oC. Image and mathematical analysis of FRAP was performed as 
follows using ImagePro Premiere (MediaCybernetics) and Excel (Microsoft). 
 FRAP is modelled on the dissociation of irreversibly bleached molecules. As such the rise in 
post-bleach fluorescence due to the exchange of such molecules with the soluble pool of 
fluorescent molecules can be modelled using the following equation (assuming that recovery can 
be described by a single exponential): 
𝑑𝑑𝑑𝑑
𝑑𝑑𝑑𝑑
=  −𝑘𝑘𝑑𝑑 
where I is the amount of irreversibly bleached molecules, t is time and k is the dissociation 
constant. Note that this model assumes that the supply of fluorescent molecules in the soluble 





where I0 is the amount of irreversibly bleached molecules immediately post-bleach (at t0). I(t) can 
be expressed as F∞ – F(t), where F∞ is the fluorescence at infinity (maximum recovery) and F(t) is 
the fluorescence at a particular time point t. I0 can be expressed as F∞ – F(0), where F(0) is the 
fluorescence immediately following photobleaching. Thus the above equation can be expressed 
as: 
𝑒𝑒−𝑘𝑘𝑘𝑘 =
𝐹𝐹∞ − 𝐹𝐹(𝑑𝑑) 
𝐹𝐹∞ − 𝐹𝐹0
 
To calculate the dissociation constant k, equation (1) can be rearranged to give:  
(1) 
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𝑘𝑘𝑑𝑑 = −ln �
𝐹𝐹∞ − 𝐹𝐹(𝑑𝑑) 
𝐹𝐹∞ − 𝐹𝐹0
� 
k is obtained by plotting the expression on the right against time and determining the gradient of 
the line of best fit given by the equation Y = kX. Once k has been determined, it can then be 
substituted into equation (1) to calculate the half-life (t½), which is defined as [(F∞ – F(t))/(F∞ – 







Note that all measured fluorescence is corrected for (i) background noise and (ii) photobleaching 
damage before being used to calculate the FRAP parameters described above.  
2.3.4 Tethering assay 
To visualise tethered checkpoint proteins tagged with fluorescent proteins, exponentially growing 
cells were obtained by growth in liquid PMG medium (no aTc, no thiamine) at 30 oC with 
shaking for 6-8 hours before diluting down in PMG medium (with aTc, no thiamine) for 12-20 
hours until an OD600 of 0.3 was reached. Cells were harvested (1701 x g, 2 min 30 s) before 
washing in 1 ml of clear PMG medium (Section 2.5.2). Following washing cells were pelleted 
(1701 x g, 2 min 30 s) before resuspension in clear PMG medium and mounting on a slide. Cells 
were imaged immediately.  
2.3.5 Synthetic arrest assay 
For strains containing Mph1 kinase fragments driven by the nmt promoter, exponentially 
growing cells were obtained by growth in liquid PMG medium (no aTc, with thiamine) at 30 oC 
with shaking for 6-12 hours to load cells with thiamine. Cell were then harvested (1701 x g, 2 min 
30 s) before being washed twice with 50 ml PMG (no aTc, no thiamine) and then split into two 
PMG cultures, one with thiamine and one without. Both cultures contained aTc and were grown 
at 30 oC with shaking for 12-20 hours, with samples taken for microscopy at regular intervals. 
Cells were imaged immediately. 
2.4 Reaction kits 
All kits were used in accordance with the manufacturer’s instructions unless otherwise stated. 
Product Name Manufacturer Catalogue Number 
Gel Extraction Kit Fermentas K0691 
Miniprep Kit Fermentas K0503 
Qiaquick PCR Purification Kit Qiagen 28104 
QuikChange® II Site-Directed Mutagenesis Kit Stratagene 200524 
QuikChange® Lightning Site-Directed Mutagenesis Kit Stratagene 210515 
Gateway® LR Clonase® II Enzyme mix Invitrogen 11791-100 
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Gateway® BP Clonase® II Enzyme mix Invitrogen 11789-020 
 
2.5 Yeast Media 
Recipes are given for liquid media. For solid media, 2% (w/v) agar was added. All media were 
sterilised by autoclaving.  
2.5.1 Yeast Extract Supplemented (YES) 
Note: YES contains thiamine which represses the nmt promoter.  
Component Final conc. 
Yeast extract 0.5 % (w/v) 
D-glucose, anhydrous 0.5 % (w/v) 
Supplements mix 1x 
 
2.5.2 Pombe minimal medium (PMG)/clear PMG medium 
PMG does not contain thiamine and thus allows for expression of nmt promoter driven genes, 
though filter-sterilised thiamine can optionally be added to a final concentration of 15 µM from a 
10 mg/ml (2000x) stock to repress expression.  
 For clear PMG medium, the same recipe was used except that D-glucose was omitted prior 
to autoclaving. Following autoclaving, filter-sterilised glucose was added to a final concentration 
of 2 % (w/v). Clear PMG medium greatly reduces the autofluorescence seen when imaging GFP-
tagged constructs as it lacks the yellow colour that results from the caramelisation of glucose 
during the autoclaving process.  
Component Final conc. 
Phtalic acid 14.7 mM 
Di-sodium hydrogen orthophosphate, anhydrous 15.5 mM 
L-glutamic acid, monosodium salt 25.4 mM 
D-glucose, anhydrous 2 % (w/v) 
Vitamins mix 1x 
Minerals mix 1x 
Supplements mix 1x 
 
2.5.3 Supplements mix (20x) 
Adenine and leucine were added at double the concentration of the other amino acids – this is 
necessary for maximum growth rate of ade- and leu- strains. The following mix was dissolved 
with gentle heating and filter-sterilised before use. 
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Component Mass 
Adenine 1.6 g 
Arginine 0.8 g 
Histindine 0.8 g 
Leucine 1.6 g 
Uracil 0.8 g 
Lysine 0.8 g 
Distilled water to 500 ml 
 
2.5.4 Minerals mix (1000x) 
The following mix was dissolved with gentle heating and filter-sterilised before use. 
Component Final conc. 
Boric acid 80.9 mM 
MnSO4 23.7 mM 
ZnSO4 . 7 H2O 13.9 mM 
FeCl3 . 6 H2O 7 mM 
Molybdic acid 2.47 mM 
KI 6.02 mM 
CuSO4 . 5 H2O 1.6 mM 
Citric acid 47.6 mM 
 
2.5.5 Vitamins mix (1000x) 
The following mix was dissolved with gentle heating and filter-sterilised before use. 
Component Final conc. 
Biotin 10 mg/l 
Pantothenic acid 1 g/l 
Nicotinic acid 10 g/l 




2.6  List of primers used in this work 
 
No.  Name Sequence (5’–3’) Comments Source 
IY01 iy_mCherry_F.4 CTTAAATGTGAAAGTGGGTCCCGGATCCCCGGGTTAATTAA To PCR mCherry for joining to 
rtTA by overlap extension PCR. 
This work. 
IY02 iy_mCherry_R.2 AGTCATTAATCTTGTACAGCTCGTCCATGCC To PCR mCherry for joining to 
rtTA by overlap extension PCR. 
This work. 
IY03 iy_rtTA_F GATCGCTAGCATGTCTAGATTAGATAAAAGT  This work. 
IY04 iy_rtTA_R.3 GGACCCACTTTCACATTTAAGT  This work. 
IY06 M1STAAF.2 TTGATGGCGAATCCGCTGCTATGAAATTGGTTG Mutagenic primer to create 
Mad1C2A. 
This work. 
IY07 M1STAAR.2 CAACCAATTTCATAGCAGCGGATTCGCCATCAA Mutagenic primer to create 
Mad1C2A. 
This work. 
IY10 iy_rtTA_seq_F TCACTAGAGAACGCGTTATATG Sequencing primer. This work. 
IY15 iy_rtTA_NLS_F GATCGCTAGCATGCCTAAAAAAAAACGTAAAGTTTCTAGATTAGATAAAAGTAAAG  This work. 
IY16 iy_rtTA_NLS_R GATCATTAATGGACCCACTTTCACATTTAAGT  This work. 
IY29 iy_mCherry_seq_F CCACAACGAGGACTACACCATC Sequencing primer. This work. 
IY49 iy_Adh1_seq_F TCTCATTGGTCTTCCGCTCCG Sequencing primer. This work. 
IY50 iy_ccdB_seq_F GTCTGCAGGTCGACCATAGTG Sequencing primer. This work. 
IY51 iy_pLYS1U_seq_F GAGTCAGTGAGCGAGGAAGC Sequencing primer. This work. 
IY55 iy_[KM]nmt1 F1 TCATCAATTGAATAAGTTGA Sequencing primer. This work. 
IY56 iy_Adh_F.2 GATCGAGGTACCGCATGCCCTACAACAACTAAG  This work. 
IY58 iy_ccdB_R.2 GATCGACTCGAGCCACTTTGTACAAGAAAGCTGAA  This work. 
   contd. next page 
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No.  Name Sequence (5’–3’) Comments Source 
IY59 iy_pLYS1U_F.2 GATCGACTCGAGGGCGCGCCACTTCTAAATAA  This work. 
IY60 iy_pLYS1U_R.2 GATCGAGGTACCATGCAAGCTTGGCGTAATCAT   This work. 
IY61 iy_pADH_mcs_F CTCGAGTCGTTCCAGATTACGCTGCTC Phosphorylated primer. This work. 
IY62 iy_pADH_mcs_R GCTAGCAATTCTCTTGCTTAAAGAAAA Phosphorylated primer. This work.  
IY64 iy_Mph1_FL_attB_R GGGGACCACTTTGTACAAGAAAGCTGGGTCCTATTCTGGCATTTTTCGTAA   
IY74 ADHterm-F CTCTTATTGACCACACCTCTACC Sequencing primer.  
IY76 lys1-Rev GTGATGTGTCTGGGAAAGGCAGAG Sequencing primer.  
IY121 iy_Mph1_303_attB_F GGGGACAAGTTTGTACAAAAAAGCAGGCTTCAAGCGTCAGCAGGACGTTG   
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2.7  List of plasmids used in this work 
 
Name Description Source 
pIY01 pDUAL-Pnmt81-2xFLAG-rtTA-mCherry-Gateway® 
Purpose: Inducible expression (Pnmt81) Gateway-compatible TetON tethering vector with mCherry tag. Backbone: pDUAL-HFF81C. Marker: ampicillin.  
Construction described in Section 2.9.1. 
This work. 
pIY02 pDUAL-Pnmt81-2xFLAG-rtTA-Gateway®  
Purpose: Inducible expression (Pnmt81) Gateway-compatible TetON tethering vector without mCherry tag. Backbone: pDUAL-HFF81C. Marker: ampicillin. 
Construction described in Section 2.9.2. 
This work. 
pIY03 pLYS1U-Padh15-NLS-2xFLAG-rtTA-mCherry-Gateway® 
Purpose: Constitutive high expression (Padh15) Gateway-compatible TetON tethering vector with mCherry tag and SV40 NLS. Backbone: pLYS1U. Marker: 
ampicillin. Construction described in Section 2.9.3. 
This work. 
pIY10 pLYS1U-Padh15-NLS-2xFLAG-rtTA-mCherry-Spc71-666-9TE 
Purpose: Tethering Spc71-666-9TE. Backbone: pLYS1U. Marker: ampicillin. Derived from pIY03.  
This work. 
 pDONR201-mph1D1-302 This work. 
 pDONR201-spc71-666-9TE This work. 
 pDONR201-spc71-666-9TA (?) This work. 
 pDONR201- mad1D1-313 This work. 
 pDONR201- mad1D1-148 This work. 
 pDONR201- mad1D1-439 This work. 
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2.8  List of fission yeast strains used in this work 
 
Strain Genotype  Source 
IY83 Pnmt81-rTetR-mCherry-mad1D1-313:leu1, tetO:kanR, mad1D::ura4  This work 
IY84 Pnmt81-rTetR-mCherry-mad1D1-148:leu1, tetO:kanR, mad1D::ura4  This work 
IY85 Pnmt81-rTetR-mCherry-mad1D1-439:leu1, tetO:kanR, mad1D::ura4  This work 
 mad1D::ura4  Hardwick lab 
 mad1-GFP:his3  Hardwick lab 
 mad2D::ura4  Hardwick lab 
IY09 mad1-C8A-GFP  This work 
IY11 mad1-M6A-GFP  This work 
IY46 mad1-C2A-GFP  This work 
IY48 Pnmt81-rtTA-mCherry-mad1D1-148:leu1, tetO:kanR, mad2-mCherry:natR  This work 
IY49 Pnmt81-rTetR-mCherry-mad1D1-148:leu1, tetO:kanR, fta3-tdT:natR  This work 
IY128 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, bub3-GFP  This work 
IY130 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, mad3-GFP  This work 
IY131 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, bub1-GFP  This work 
IY146 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, bub1-GFP  This work 
IY184 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, mph1D:natR, bub1-GFP  This work 
IY185 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, mph1D:natR, mad3-GFP  This work 
IY188 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, mph1D:natR, bub3-GFP  This work 
IY191 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, mad3-GFP, bub3D::ura4  This work 
  contd. next page 
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Strain Genotype  Source 
IY192 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, bub1-GFP, bub3D::ura4  This work 
IY195 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, Pnmt81-rTetR-mph1D1-302:leu1, mad2-GFP  This work 
IY230 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, Pnmt81-rTetR-mph1D1-302:leu1, mad2-GFP  This work 
IY221 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, Pnmt81-rTetR-mph1D1-302:leu1, mad2-GFP  This work 
IY227 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, Pnmt81-rTetR-mph1D1-302:leu1, mad1D::ura4, mad2-GFP  This work 
IY235 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, Pnmt81-rTetR-mph1D1-302:leu1, mad3-GFP  This work 
IY239 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, Pnmt81-rTetR-mph1D1-302:leu1, mad2-GFP, pcp1-mCherry:kanR  This work 
IY241 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, Pnmt81-rTetR-mph1D1-302:leu1, mad1D:ura4::adh21-rTetR-mad1D1-148:natR, tetO:kanR, mad2-GFP  This work 
IY242 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, Pnmt81-rTetR-mph1D1-302:leu1, mad2-GFP, fta3-tdT:natR  This work 
IY245 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, mad3D::ura4, mad3-G146V-NLS-GFP  This work 
IY246 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, mad3D::ura4, mad3-NLS-GFP  This work 
IY247 lys1::Padh15-rTetR-mCherry-spc71-666-9TE:ura4, tetO:kanR, mad3D::ura4, mad3-H144V-NLS-GFP  This work 
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2.9 Plasmid construction 
2.9.1 pIY01 (pDUAL-Pnmt81-2xFLAG-rTetR-mCherry-Gateway®) 
The rTetR gene (encoding rTetR) was amplified from pAK2 (gift from Alexander Kagansky) 
using primers 3 and 4 and joined to a mCherry fragment amplified out from pFA6a-mCherry-
natR using primers 1 and 2 by overlap extension PCR. After purification this combined rTetR-
mCherry fragment was digested with NheI and AseI and ligated to pHFF81C (gift from Ken 
Sawin) digested with NheI and NdeI. The resulting plasmid was sequenced using primers 10 and 
29. This plasmid is Gateway® cloning compatible.  
2.9.2 pIY02 (pDUAL-Pnmt81-2xFLAG-rTetR-Gateway®) 
The rTetR gene (encoding rTetR) was amplified from pAK2 (gift from Alexander Kagansky) 
using primers 3 and 16. After purification this rtTA fragment was digested with NheI and AseI 
and ligated to pHFF81C (gift from Ken Sawin) digested with NheI and NdeI. The resulting 
plasmid was sequenced using primers 10. This plasmid is Gateway® cloning compatible. 
2.9.3 pIY03 (pLYS1U-Padh15-NLS-2xFLAG-rTetR-Gateway®) 




Fig. 2.1 – Engineering an improved tethering vector, pIY03. (A) pRAD15 was amplified using phosphorylated 
primers 61 & 62 before DpnI digestion and ligation to form pIY09. This re-created the pRAD15 vector with 
new NheI and XhoI restriction sites which were then used to insert a PCR fragment comprising of NLS-rt-
TA-mCherry-FLAG-Gateway® (C) (amplified using primers 15 and 58 from pIY01 (B)). pIY09 was then used as 
a template to PCR amplify out P
adh15
-NLS-rtTA-mCherry-2xFLAG-Gateway® using primers 56 and 58 (D), which 
was subsequently joined to a PCR fragment containing the pLYS1U backbone (primers 59 and 60) (E) using 
KpnI and XhoI to form pIY03 (F). This new construct was verified by sequencing using primers 49, 50 and 51 
and is Gateway® recombination compatible.
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Phosphorylation of a C-terminal Mad1 fragment is 
sufficient for C-Mad2 recruitment 
3.1 Introduction: the usefulness of ectopic tethering systems 
When studying complex signalling pathways with defined triggers such as the spindle checkpoint, 
a simple yet powerful approach is to separate the trigger from the rest of the signalling pathway; 
this often reveals important insights into how the signal is generated and propagated in both 
space and time. As detailed in Chapter 1, many studies of the spindle checkpoint have sought to 
adopt this approach and temporally separate the origin of the checkpoint signal at the 
kinetochores from the rest of the signalling pathway.  
 In human-derived cells, constitutive tethering of Mad1 to the kinetochores by fusing it with 
the outer kinetochore component Mis12 (part of the conserved KNL1-Mis12-Ndc80 complex) 
was found to constitutively localise Mad2 to the kinetochores and activate the spindle checkpoint, 
even after proper bi-orientation was achieved (Kuijt et al., 2014; Maldonado and Kapoor, 2011). 
A similar experimental setup was adopted in S. pombe by Ito and colleagues when Ndc80 was 
used as an anchor with which Mph1 kinase was constitutively tethered to kinetochores (Heinrich 
et al., 2012; Ito et al., 2012). This produced constitutive kinetochore localisation of Bub1 and 
activation of the spindle checkpoint. Although Mad1 and Mph1 normally localise to the 
kinetochores when the spindle checkpoint is activated, by artificially forcing the interaction these 
two studies have turned the kinetochores into a constitutive checkpoint signal (MCC) generator 
that may temporally uncouple the checkpoint trigger at the kinetochores from the rest of the 
checkpoint signalling pathway.  
 Although both of these kinetochore tethering studies yielded interesting insights into spindle 
checkpoint signalling, their experimental approach suffers from a serious drawback in that the 
fusion of kinetochore and spindle checkpoint components risks unintentionally activating the 
spindle checkpoint by disrupting microtubule-kinetochore interactions or by perturbing 
kinetochore structure itself. Maldonado and colleagues attempted to discount these possibilities 
by showing that their mCherry-Mis12-Mad1 construct does not affect the localisation of various 
spindle checkpoint and kinetochore components (Bub1, CENP-E, RZZ components &etc.) and 
that it is capable of supporting normal chromosome segregation when the Mad1 in the construct 
was replaced by a Mad1 mutant unable to bind Mad2 (Maldonado and Kapoor, 2011). However, 
Ito and colleagues only demonstrated that their kinetochore tethered Ndc80-Mph1 fusion 
generates a checkpoint-dependent arrest that is Mad2 dependent and thus presumably does not 
inactivate checkpoint function; no evidence ruling out checkpoint activation through disruption 
of kinetochore-microtubule interaction or kinetochore structure was presented (Ito et al., 2012). 
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 An alternative method of uncoupling spindle checkpoint signalling from its kinetochore 
trigger is to spatially separate the site of checkpoint signalling away from the kinetochore; our lab 
was the first to demonstrate the usefulness of this approach by ectopically tethering the Bub1 
scaffold protein to S. pombe telomeres; this proved sufficient to recruit the downstream partners 
of Bub1: Bub3 and Mad3 (Rischitor et al., 2007). A similar approach proved useful in the study of 
the DNA damage pathway in human-derived cells; by tethering LacI-tagged fusions of DNA 
damage signalling components to a chromosome arm containing LacO repeats, Bonilla and 
colleagues were able to spatially separate the assembly of DNA damage signalling components 
from the double-strand break (DSB) sites that normally serve as the trigger of the pathway 
(Bonilla et al., 2008).  
 Artificially moving the spindle checkpoint components away from the kinetochore in the 
way described above allows a key question of spindle checkpoint assembly to be addressed: is a 
high local concentration of spindle checkpoint components sufficient for checkpoint signalling? 
If true, then it would be expected that artificially concentrating basal spindle checkpoint 
components such as Mad1, Bub1, Spc7 and Mph1 at an ectopic site away from the kinetochores 
should be sufficient to drive kinetochore-independent assembly of MCC. If successful, this 
approach can be expected to produce an informative reductionist picture of the minimal 
requirements for spindle checkpoint signalling, both in terms of the checkpoint proteins as well 
as any PTMs that may also be required. 
 With this goal in mind, this chapter will describe how an ectopic tethering system was 
developed in S. pombe and how the system proved to be capable of artificially re-creating one of 
the key steps in the activation of the spindle checkpoint: the Mad1-dependent recruitment of 
Mad2.  
3.2 Designing an ectopic tethering system in S. pombe 
To create an effective ectopic tethering system in S. pombe, the proven tetracycline-controlled 
transcriptional activation system was adapted for use in S. pombe. The original tetracycline-
controlled transactivator system (Gossen and Bujard, 1992) was based on a tetracycline repressor 
(TetR) protein derived from E. coli that is capable of binding to both the antibiotic tetracycline as 
well as a cis-acting 19 bp tet operator sequence (tetO). When TetR is fused with an activation 
domain, such as the virion protein 16 of herpes simplex virus (VP16), the resulting 
transcriptional transactivator (tTA) fusion protein is capable of driving transcription when it is 
bound to tetO sites placed near a minimal promoter of the target gene. Two versions of this 
system exists. Under the original system, now commonly referred to as TetOFF, the tTA fusion 
protein is bound to tetO sites and thus activates transcription in the absence of tetracycline. In the 
TetON system, point mutations in the TetR protein produces a reverse transcriptional 
transactivator (rtTA) fusion that binds to tetO sites only in the presence of tetracycline. 
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 The ectopic tethering system used in this work is based on the TetON system and is 
comprised of two parts. The first part is the ectopic location to which tethered checkpoint 
proteins will be targeted, which is defined by an array consisting of 112 tandem copies (5.6 kb) of 
tetO sequence integrated at the arg3 locus on chromosome I (2273765-2275516) (Fig. 3.1A). The 
location for this array was chosen to ensure that there was sufficient spatial separation between it 
and the centromere (3753687-3789421) as well other chromosomal features that might perturb 
ectopic spindle checkpoint signalling, such as telomeres. The array is marked with the G418 drug 
resistance (kanR) gene for selection.  
 The second part of the system is the protein to be tethered, which is expressed from a 
tethering vector (pIY01) based on the pDUAL plasmid (Matsuyama et al., 2004). Construction 
details can be found in (Section 2.9.1). The checkpoint protein to be tethered is cloned into pIY01 
using Gateway® recombination, which fuses it to an N-terminal reverse TetR (rTetR) protein that 
enables regulated binding to the tetO array and (optionally) a fluorescent tag such as mCherry or 
GFP to enable visualisation of the tethered checkpoint protein. A double FLAG tag, also N-
terminal to the tethered protein, provides a biochemical handle for co-immunoprecipitation of 
tethered proteins as well as a mean of detection by immunoblot. Expression of the whole 
construct is driven by a weak inducible no message in thiamine (nmt81) promoter (Basi et al., 
1993; Maundrell, 1993).  
 Once the checkpoint protein to be tethered is expressed in a yeast strain containing the tetO 
array, localisation of the tethered protein is achieved through the addition of a tetracycline 
derivative, anhydrotetracycline (aTc) (Section 2.3.1) to the medium. Interaction between the 
tethered protein and fluorescently tagged downstream partners can then be visualised as co-
localising fluorescent foci. Unlike the original TetOFF system, which responds to both 
tetracycline and its derivatives such as doxycycline and anhydrotetracycline, the TetON system 
only responds to the latter. Although costlier than doxycycline, anhydrotetracycline is the 
preferred derivative due to its lower working concentration (10 µM final).  
3.3 Using ectopic tethering to examine Mad1-Mad2 interaction 
As a checkpoint scaffold, the main function of Mad1 is to bind stably associated Mad2 (C-Mad2) 
and thus provide a template for the conversion of dynamically cycling O-Mad2 to C-Mad2 (De 
Antoni et al., 2005). As described in Chapter 1, S. pombe Mad1 is a 689 amino acid protein that 
can be approximately divided into five coiled coil domains. How these coiled coils contribute to 
the ability of Mad1 to bind Mad2 or its ability to stimulate Mad2:Mad2 dimerisation remains 
unclear. The Mad2 binding site on Mad1 consists of a small (~20 a/a) C-terminal stretch that lies 
near coiled coil 4 (Fig. 3.1B). Crystallography data from the hsMad1:hsMad2 complex suggests 
that the C-terminus of Mad1 folds-back onto Mad1 close to the Mad2 binding site, and this fold-
back has been hypothesised to be important for the ability of Mad1 to bind Mad2 or to induce 
Mad2:Mad2 dimerisation (Musacchio et al., 2002). Heinrich and colleagues attempted to test this 
directly by mutating or deleting C-terminal portions of Mad1 that were predicted to interfere 
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Fig. 3.1 – Ectopic tethering of Mad1 fragments. (A) Schematic of ectopic tethering system for synthetic 
spindle checkpoint signalling from chromosome arm. (B) Schematic of S. pombe Mad1 showing coiled coil 
structure and Mad2 binding site, along with N-terminal truncations based on these coiled coil domains. (C) 
Cross-linking map of S. pombe Mad1:C-Mad2 tetrametric complex. Purple lines denote intra- or 
inter-molecular cross-links. Red lines denote inter-molecular cross-links. Note long range cross-link between 
N and C terminus of Mad1 suggesting fold back of Mad1. Cross-linking co-immunoprecipitation performed by 
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with its folding-back, and it was found that neither of the mutants tested exhibited perturbed 
Mad1-C-Mad2 or C-Mad2-O-Mad2 interaction (Heinrich et al., 2014).  
 This chapter sets out to examine the role of Mad1 coiled coils in both Mad1-C-Mad2 and C-
Mad2-O-Mad2 complex formation in two ways. First, the coiled coils of Mad1 will be truncated 
from the N-terminus and the resulting Mad1 fragments will be ectopically tethered to a 
chromosome arm; the ability of these fragments to form Mad1-C-Mad2 complexes will be tested 
in vivo by assaying for Mad2-GFP recruitment. If Mad1-C-Mad2 complexes are visualised, then 
the ability of these complexes to support C-Mad2-O-Mad2 complex formation will be tested by 
measuring Mad2 turnover by FRAP. Second, mass spectrometry data from previous work in our 
lab was used to generate a series of Mad1 phospho-mutants; these will be used to examine if 
phosphorylation of Mad1 plays a role in regulating its interactions with Mad2 in S. pombe. 
3.4 Mad1 coiled coils 1-3 not required for stably associated Mad2 binding 
To examine whether the N-terminal coiled-coils of Mad1 are required for its ability to bind Mad2 
in vivo, a series of N-terminal truncations of Mad1 was made (Fig. 3.1B). A GFP-tagged fragment 
of Mad1 with its first N-terminal coiled coil (coiled coil 1) truncated proved capable of localising 
to the ectopic array and forming distinct GFP foci in interphase cells (Fig. 3.2A). These GFP foci 
do not co-localise with an Fta3-tdT kinetochore marker, demonstrating that the GFP foci 
observed are not the result of Mad1 localising to kinetochores. Fta3 serves as a kinetochore 
marker by virtue of being a component of the Mis6 centromeric complex that associates with the 
kinetochore throughout the cell cycle (Liu et al., 2005).  
 As the cells shown in Fig. 3.2A are taken from asynchronous cultures, a small proportion of 
the population (~10-15 %) can be expected to be mitotic; in these cells Mad1-GFP foci are 
observed at both kinetochores as well as the ectopic array (data not shown). It should be noted 
that removal of coiled coil 1 from Mad1 also removes the ability of Mad1, and hence Mad2, to 
localise to the nuclear periphery during interphase (Lee et al., 2008). This explains why cells 
shown in Fig. 3.2A do not exhibit a distinctive ‘Mad2-GFP ring’ that is formed by Mad2-GFP-
Mad1 complexes localised around the nuclear periphery during interphase. The loss of this 
Mad2-GFP ring pattern is desirable for technical reasons as GFP foci formed by tethered Mad2-
GFP-Mad1 complexes near the nuclear periphery are often partially obscured by the Mad2-GFP 
ring.  
 Strikingly, the removal of coiled coils 2 and 3 from Mad1 does not impair its ability to recruit 
Mad2 (Fig. 3.2B). As Mad1 normally exists as a dimer, it may have been possible for tethered 
molecules of Mad1 to recruit Mad2 to the array by heterodimerising with endogenous molecules 
of Mad1; to exclude this possibility, the strains presented in Fig. 3.2B were made in a mad1D 
background. When interpreting these results it should be noted that, as detailed in Chapter 1, 
Mad2 exists in two structurally distinct forms: a stably associated C-Mad2 form that is bound to 
Mad1 and a dynamically O-Mad2 form that is free to bind Cdc20. Thus, while the images 
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Fig. 3.2 – N-terminal coiled coils of Mad1 are dispensable for C-Mad2 recruitment. (A) Ectopically tethered 
Mad1
∆1-148
-GFP fragment does not localise to kinetochores. A Mad1
∆1-148
 fragment lacking the first N-terminal 
coiled coil was GFP-tagged and tethered to a tetO array on a chromosome arm (green). fta3-tdT: kinetochore 
marker (red). (B) Ectopically tethered Mad1 fragments capable of recruiting C-Mad2. Mad2-GFP forms 
co-localising foci in interphasic cells expressing ectopically tethered Mad1 fragments tagged with mCherry. 

























presented here demonstrate that the first three N-terminal coiled coils of Mad1 are dispensable 
for its ability to ectopically recruit the stably associated form of Mad2 (C-Mad2), FRAP 
experiments would be required before the impact of these coiled coils on the ability of Mad1 to 
recruit dynamic O-Mad2 can be assessed. This forms the subject of the subsequent section 
(Section 3.5). 
 More importantly, tethering of these Mad1 truncations was not sufficient to activate the 
spindle checkpoint, as evidenced from the morphology and viability of the strains imaged after 
the induction of nmt promoter driving Mad1 expression. This agrees with other studies where 
Mad1 tethering to chromosome arms was found to be unable to activate the checkpoint, and 
suggests that the co-localisation of other checkpoint components is required for checkpoint 
activation.  
3.5 Ectopically recruited Mad2 is more dynamic than tethered Mad1Δ1-148 
To determine if the N-terminal coiled coils of Mad1 are required for its ability to recruit 
dynamically cycling Mad2 (O-Mad2), the dynamics of ectopically tethered Mad1Δ1-148 and that of 
Mad2 being recruited by this fragment of Mad1 were measured by FRAP. It was necessary to first 
determine the dynamics of tethered Mad1 before Mad2 dynamics could be considered because 
although kinetochore-bound Mad1 is known to be highly stable, this could not be assumed to be 
the case for ectopically tethered Mad1, which may be isolated from kinetochore-specific factors 
that may affect its dynamics, such as phosphorylation by kinetochore-bound Mph1 kinase. 
Unfortunately, full-length Mad1 proved technically impossible to FRAP reliably due to low signal 
to noise ratios and the difficulty associated with trying to identifying Mad2-GFP foci that were 
not at least partly obscured by the ring of Mad2-GFP around the nuclear periphery (see above). 
Nevertheless, ectopically tethered Mad1Δ1-148-GFP was found to have a low rate of turnover and 
recovery (Fig. 3.3B, half-time: 125 ± 33s, recovery = 43 ± 12 %, n = 5) compared to the Mad2-GFP 
recruited by Mad1 Δ 1-148 (Fig. 3.3C, half-time: 87 ± 33s, recovery = 88 ± 20 %, n = 6), suggesting 
that Mad1 Δ 1-148 is more stable associated at the ectopic site than Mad2, as expected. 
 Published Mad1 and Mad2 dynamics vary considerably depending on the experimental 
setup and interpretation applied. For Mad1, in vivo data from higher eukaryotes including 
Drosophila, PtK2 and HeLa cells present a wide range of recovery levels for Mad1 (10 – 45 %) at 
unattached kinetochores, with more recent studies suggesting that vertebrate Mad1 may be more 
dynamic than previously envisaged (Défachelles et al., 2015; Howell et al., 2004; Matson and 
Stukenberg, 2014; Shah et al., 2004). The differences in methodology between these higher 
eukaryotic studies and the present work limit the meaningfulness of direct comparisons of FRAP 
parameters; indeed, the level of variation within the higher eukaryotic data limits even the 
meaningfulness of direct comparisons within these model systems. More importantly, the 
recovery level of tethered Mad1Δ1-148 obtained here (43 ± 12 %) agrees with unpublished data from 
our lab of full length Mad1 dynamics measured at S. pombe kinetochores in strains arrested using 
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Fig. 3.3 – C-Mad2 more dynamic than tethered Mad1
∆1-148 at ectopic array. (A) Schematic of Mad2 cycling on 
tethered Mad1
∆1-148
. (B) FRAP of Mad1
∆1-148
-GFP. GFP foci formed by Mad1
∆1-148
 tethered to ectopic array was 
photobleached with a laser, and images captured at the specified intervals throughout the recovery period. 
The % fluorescence recovery and half-times shown are the mean of the indicated number of experiments. 
Error bars indicate standard deviation. The red line indicates the 50 % post-bleach recovery level. (C) FRAP of 
Mad2-GFP recruited by tethered Mad1
∆1-148
. GFP foci formed by Mad2-GFP recruited by tethered 
Mad1
∆1-148
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the cold-sensitive nda3 mutation (recovery = 54 ± 13 %; Karen May, personal communication, 
cited with permission).  
 Regarding the half-life of Mad1, several of the above studies argue that Mad1 exhibits a bi-
phasic recovery with an initially fast recovery phase (half-time: 12 – 18 s) followed by a much 
slower recovery phase (half-time: 15 – 145 min.). Whether Mad1 does in fact exhibit a bi-phasic 
recovery in all the examples cited in these studies is debatable; careful examination of the 
recovery profiles presented by Matson and Stukenberg (Fig. 2D, control curve; Matson and 
Stukenberg, 2014) and Howell et al. (Fig. 3; Howell et al., 2004) shows that, during the period 
after Mad1 recovery reaches its plateau, there is negligible recovery and thus measurements made 
during this period are arguably meaningless. This would however explain some of the unusually 
long Mad1 half-times reported by these studies (up to 145 min.). Nevertheless, these studies 
together present a picture where a relatively small pool of Mad1 turns over rapidly whilst the bulk 
of Mad1 remains stably associated with the unattached kinetochores.  
 Contrary to these studies, the Mad1Δ1-148 recovery profile presented here is not indicative of a 
bi-phasic recovery, as Mad1Δ1-148-GFP levels reach their peak in a gradual manner. This difference 
in recovery profile and half-time may be due to (i) the truncation of first N-terminal coiled coil of 
Mad1, (ii) the absence of kinetochore-specific post-translational modifications on ectopically 
tethered Mad1Δ1-148, or (iii) methodological differences. These possibilities form important 
questions for the future. The first possibility will be addressed by using an improved tethering 
vector, described later in Chapter 4, which should improve the signal to noise ratio of tethered 
full-length Mad1, whilst the second question will be addressed analysis of Mad1 phosphomutants 
in the following section (Section 3.6). It should be noted here before this data can be usefully 
interpreted it will be essential to measure tetR turnover rates at the ectopic array; without 
correcting for this turnover it will be impossible to know what proportion of the observed GFP 
dynamics are attributable to modifications of Mad1, and what portion is attributable simply to 
tetR turnover.  
 It is perhaps for these same reasons that the half-time of Mad2 recruited by tethered Mad1Δ1-
148 (Fig. 3.2C, half-time: 87 s) differs from the published vertebrate data (half-time: 1.7 – 26 s) 
(Vink et al., 2006). Published Mad2 recovery levels from both in vitro and in vivo studies agree 
that because the Mad1-C-Mad2 interaction is highly stable and thus photobleached Mad2 
molecules in this Mad1-bound pool do not recover during the course of a typical FRAP 
experiment, approximately half of the Mad2 population can be expected to recover in 
experimental setups where Mad1 is immobilised and soluble Mad2 is provided either by transient 
transfection or direct injection (Howell et al., 2000; Shah et al., 2004). In contrast, when the Mad2 
present in the Mad1-C-Mad2 complex is allowed to exchange, higher Mad2 recovery rates close 
to 100 % were observed (Howell et al., 2004). The same would be expected if a certain proportion 
of the Mad1 population were to turn over, and the high Mad2 recovery rate (88 %) obtained is 
likely a direct result of the higher than expected turnover of Mad1Δ1-148 described earlier.  
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3.6 Phosphorylation of Mad1 C-terminus crucial for C-Mad2 binding 
To determine if phosphorylation of Mad1 played a role in regulating Mad2 interactions in S. 
pombe, two set of alanine (non-phosphorylatable) substitutions were made in Mad1 based on 
mass spectrometry data. These were named according to the number of alanine substitutions that 
they contained and the approximate location of these mutations: mad1-M6A, which contains six 
substitutions in the middle region of Mad1, and mad-C8A, which contains eight substitutions 
near the C-terminus of Mad1. A summary of these mutations is shown in Fig. 3.4A. Both of these 
mutant strains were also C-terminally tagged with GFP to enable them to be used with 
microscopic and biochemical assays.  
 To assess if these substitutions affect spindle checkpoint function, mad1-C6A-GFP and 
mad1-C8A-GFP mutants were first subjected to the microtubule depolymerising drug benomyl. 
As shown in Fig. 3.4B, the mad1-C8A-GFP mutant exhibits a strong sensitivity to benomyl, 
suggesting that it may be checkpoint deficient, whilst the mad1-M6A-GFP mutant appeared 
unaffected by benomyl. To determine if the benomyl sensitivity of the mad1-C8A-GFP mutant 
corresponded to a specific checkpoint defect, the ability of mad1-C8A-GFP to bind C-Mad2 was 
tested. Strikingly, the ability of the mad1-C8A-GFP mutant to co-immunoprecipitate with Mad2 
is greatly diminished compared to Mad1-GFP, whilst the mad1-M6A-GFP mutant is 
undiminished in its Mad2 binding ability (Fig. 3.4C). It should be noted here that only the stably 
associated form of Mad2 (C-Mad2) is detectable by co-immunoprecipitation; the interaction 
between O-Mad2 and the Mad1-C-Mad2 complex is likely too weak to be preserved during the 
co-immunoprecipitation process. Taken together, these results suggest that phosphorylation of 
Mad1 along its C-terminus is likely essential for its ability to form the stable Mad1-C-Mad2 
scaffold and presumably its ability to activate the spindle checkpoint.  
 These results form the basis of ongoing work. The strong benomyl sensitivity exhibited by 
the mad1-C8A-GFP mutant combined with its inability to co-immunoprecipitate Mad2 point to a 
checkpoint activation defect that will be tested by assessing its ability to arrest in the cold-
sensitive microtubule-depolymerising nda3 background. Ectopic tethering of mad1-C8A and 
assaying of its ability to ectopically recruit Mad2 will provide important in vivo confirmation of 
the loss of Mad2 binding ability described above. In addition, the creation of a phosphomimetic 
mad1-C8E-GFP mutant that may exhibit stronger/constitutive Mad2 binding should provide 
further confirmation of the importance of these sites.  
 It is unlikely that all eight residues mutated in the mad1-C8A-GFP mutant contribute equally 
to the observed phenotype, and thus a new mutant containing only two of these two 
substitutions, mad1-C2A-GFP, has been created in an attempt to narrow down the most 
important residues. The mad1-C2A-GFP mutant does not exhibit sensitivity to benomyl (Fig. 
3.4B), and is yet diminished in its ability to co-immunoprecipitate with Mad2 (Fig. 3.4C), albeit 
not to the same extent as the mad1-C8A-GFP mutant.  
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Fig. 3.4 – Phosphorylation of Mad1 C-terminus crucial for C-Mad2 binding. (A) List of predicted Mad1 
phosphorylation sites mutated to alanine (A) and their relative positions on Mad1. All mutants were 
C-terminally tagged with GFP. Note that mad1-C2A-GFP is a subset of mad1-C8A-GFP, with the relevant 
residues indicated with an asterisk (*). (B) Mad1 C-terminal phosphomutants (mad1-C8A-GFP and 
mad1-C2A-GFP) exhibit benomyl sensitivity indicative of spindle checkpoint defect. Serial dilutions of each 
strain was plated on 8.0 µg/ml benomyl and YES plates as indicated. (C) mad1-C8A-GFP and mad1-C2A-GFP 
defective in C-Mad2 binding. Extracts from asynchronous cultures of the indicated strains were 
co-immunoprecipitated using anti-GFP.
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 The reduced ability of the mad1-C2A-GFP mutant to bind stably associated Mad2 without 
exhibiting any obvious benomyl sensitivity can be understood in light of the work of Heinrich 
and colleagues (Heinrich et al., 2012) showing that at least in S. pombe, Mad2 is a highly 
abundant checkpoint component that can still mediate a robust checkpoint response even when 
its levels are reduced by up to 35 %. Moreover, benomyl sensitivity is a crude assay of spindle 
checkpoint activity that does not always detect subtle checkpoint defects. Thus, the absence of 
benomyl sensitivity shown by the mad1-M6A-GFP mutant, or even indeed its inability to co-
immunoprecipitate with Mad2 does not preclude the presence of a subtle checkpoint defect; such 
a defect may be mediated by reduced, but not abolished, ability to recruit dynamically cycling 
Mad2. To detect such subtle checkpoint defects, the ability of the mad1-M6A-GFP and mad1-
C2A-GFP mutant to arrest in a nuf2-3 background will be tested. nuf2-3 is a temperature-
sensitive allele of the gene encoding the conserved centromeric protein Nuf2 (Nabetani et al., 
2001); upon shifting to the restrictive temperature, nuf2-3 strains arrest in a checkpoint-
dependent manner with the spindle intact. Compared to the cold-sensitive nda3-KM311 allele in 
which microtubules are completed depolymerised upon shifting to the restrictive temperature, 
the nuf2-3 allele often allows identification of more subtle checkpoint defects. Should a subtle 
checkpoint phenotype be detected in these strains, any potential defects in Mad2 cycling 
dynamics will be assessed by FRAP of tethered mad1-M6A-GFP/mad1-C2A-GFP.  
3.7 Conclusions and perspectives 
This chapter demonstrated the usefulness of an in vivo ectopic tethering assay as a way of 
complementing biochemical approaches in the investigation of complex interactions within the 
spindle checkpoint. This is most easily appreciated when one considers the problems associated 
with alternative in vivo approaches to addressing the central question of this chapter i.e. the 
function of the N-terminal coiled coils of Mad1. One such approach would have been to replace 
endogenous Mad1 with N-terminally truncated fragments and then assay for C-Mad2 binding 
using a Mad2-GFP reporter. While seemingly obvious, this approach is fraught with technical 
risks. Truncation of the first coiled coil of Mad1 would abolish its nuclear periphery localisation, 
meaning that Mad1-C-Mad2-GFP complexes would only be expected to be observable during a 
checkpoint-induced metaphase arrest, when they would presumably appear as GFP foci on the 
kinetochores. Although checkpoint arrest could be achieved using a variety of mutant 
backgrounds such as nda3, if truncation of any of the coiled coils of Mad1 were to inactivate the 
checkpoint, then it be impossible to determine whether the loss of Mad1 coiled coils disrupted 
Mad2 interaction, or indeed if this was the cause of checkpoint inactivation. By contrast, 
ectopically tethered Mad1 truncations allow its interactions with Mad2 to be easily visualised 
completely independently of the ability to these truncation to support checkpoint function. 
Moreover, investigating the effects of Mad1 truncations on Mad2 cycling dynamics without 
ectopically tethering Mad1 would have required performing FRAP on Mad1-C-Mad2 complexes 
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at unattached kinetochores, which is technically challenging due to the propensity of 
kinetochores to move during imaging.   
 In summary, this chapter has shown that a minimal fragment of Mad1 lacking all but the last 
two coiled coil domains is sufficient to recruit stably associated C-Mad2, and that this binding is 
likely dependent on the phosphorylation of key sites along the C-terminus of Mad1. Whether the 
N-terminal coiled coils of Mad1 or the phosphorylation of its C-terminus are required for the 
recruitment of dynamically cycling Mad2 remains important work for the future. More 
importantly, the ectopic tethering of Mad1 here has reproduced previous findings that ectopic 
localisation of Mad1 away from the kinetochores is by itself is insufficient to activate the 
checkpoint (Maldonado and Kapoor, 2011), and that the combinatorial action of Mad1 and Bub1 
scaffolds is likely required for checkpoint activation. This will be tested in the following chapter. 
Finally, the work presented thus far has shown that, on a technical level, the ectopically tethering 
system has scope for improvement and expansion to enable more complex and interesting 





Phosphomimetic Spc71-666-9TE is sufficient to recruit 
Bub1, Bub3 and Mad3 in a manner comparable to that at 
endogenous kinetochores 
4.1 Introduction 
The preceding chapter described the usefulness of a simple ectopic tethering system in studying 
one of the most well characterised interactions in the spindle checkpoint, that between Mad1 and 
Mad2. More importantly, it identified aspects of the system that could be improved upon; in this 
chapter the ectopic tethering construct is re-engineered to determine if the tethering system can 
be expanded upon to faithfully reproduce a much more complex set of interactions in the 
checkpoint signalling pathway, that between the core kinetochore protein Spc7 and its 
downstream partners, Bub3, Bub1 and Mad3. More importantly, whether ectopic recruitment of 
these checkpoint component is sufficient to ectopically generate MCC will be tested.   
4.2 Interplay between Bub3, Bub1, Mad3/BUBR1 and Spc7/KNL1  
As demonstrated in Chapter 3, the ectopic tethering assay provides a simple and highly flexible 
way of investigating interactions between the Spc7-Bub3-Bub1 complex and Mad3. Moreover, an 
ectopic MCC generator will almost certainly require the recruitment of Mad3 to the array via 
some arrangement of Spc7/Bub1/Bub3 – would this be sufficient to generate a strong enough 
checkpoint signal to trigger metaphase arrest, or will co-tethering with Mad1/Mad2, as described 
in the preceding chapter, also be required? 
 Thus, this chapter sets out to determine the following: 
1. Whether Spc7 can be exploited in a tethering system to recruit the Bub1 scaffold protein 
in a Bub3-dependent manner; 
2. If the above is true, then whether the recruitment of Bub1 and Bub3 is also sufficient to 
recruit Mad3, a critical component of the MCC; 
3. Whether Mph1 kinase activity be required for any of the above interactions; 
4. If Mad3 recruitment to the tether was observed, whether it would exhibit the dynamic 
cycling behaviour that is observed at endogenous kinetochores and which is likely 
essential for its ability to form MCC; 
5. Finally, whether tethered Spc7 would be sufficient for checkpoint arrest.  
4.3 Selecting the right fragment of Spc7 to tether 
In order to address the question of whether Spc7 could be used to recruit Bub1 in a Bub3-
dependent manner, the fragment of Spc7 to be tethered must contain two important features. 
First, it must incorporate the nine threonine (T) to glutamic acid (E) substitutions along the 
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MELT motifs that mimic phosphorylation by Mph1 required for Bub1 binding. This is because 
the phosphorylation of Spc7 along its MELT motifs required co-localised Mph1 (Shepperd et al., 
2012). Second, it is important that the tethered Spc7 fragment is unable to localise to 
kinetochores, so as not to leave it in a ‘tug-of-war’ with conflicting localisation signals targeting it 
to both the tetO array and the kinetochores. This would likely partition the intracellular pool of 
tether-able Spc7 into at least three pools (kinetochore-bound, array-bound and unbound), thus 
making it difficult to attribute any observed phenotypes to the ectopic array.   
 With these requirements in mind, an N-terminal fragment of Spc7, Spc71-666-9TE, was used 
as the tethered fragment of Spc7 (Fig. 4.1A). This fragment has previous been shown to be capable 
of co-immunoprecipitating with Bub1 in yeast extracts (Shepperd et al., 2012). As the figure 
shows, this mutant of Spc7 contains the key phosphomimetic MELT motifs whilst lacking the C-
terminal kinetochore localisation domain, thus making it an ideal Spc7 fragment for ectopic 
tethering. However, initial attempts to tether Spc71-666-9TE using the same tethering construct 
used previously in Chapter 3 (pIY01) resulted in low levels of Spc7 expression that were difficult 
to detect by fluorescence microscopy, making it impossible to reliably assay for ectopic Bub1-GFP 
and Bub3-GFP recruitment (data not shown). Together with the technical limitations 
encountered in Chapter 3 when examining Mad1-Mad2 interactions, it became clear that 
improvements to the tethering assay would first be required before Spc7-Bub3-Bub1-Mad3 
interactions could be studied.   
4.4 Re-engineering the tethering construct 
Work done using the ectopic tethering assay described in Chapter 3 identified four aspects of the 
tethering system with scope for improvement.  
 First, the inducible nmt81 promoter driving the expression of the tethered protein produced 
variable levels of expression between individual cells, and while this was not problematic when 
addressing simple questions such as whether Mad1 fragments could interact with stably-
associated Mad2, it did present a problem when cycling dynamics were investigated using FRAP 
assays that are highly sensitive to cell-to-cell variability in fluorescence levels.   
 Second, whilst the nmt81 promoter provided sufficient levels of Mad1 expression for the 
visualisation of both Mad1 itself at the ectopic array (via the mCherry tag) as well as its 
recruitment of Mad2-GFP, it cannot be assumed that this level of expression would be sufficient 
for other tethered proteins, such as Spc7, to recruit their downstream signalling partners. 
 Third, the tethering construct produced fusion proteins that lacked an artificial NLS, thus 
relying on the presence and function of endogenous NLS sequences on the tethered protein. 
Although the truncations of the Mad1 protein described thus far have not caused deficiencies in 
the nuclear localisation of Mad1, the same assumption cannot reliably be made of other 
checkpoint proteins.  
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 Lastly, the number of tether-able checkpoint proteins that can be expressed at any given time 
was limited to one, given that the tethering construct relied on the pDUAL plasmid backbone for 
integration into the yeast genome at the LEU1 locus. Whilst this is not a limitation of the system 
per se, additional loci from which tether-able constructs could be expressed would be required 
before multiple checkpoint components could be tethered together simultaneously. 
 These four limitations were overcome by almost completely re-engineering the tethering 
constructs to generate pIY03 (pLYS1U-Padh15-NLS-2xFLAG-rtTA-mCherry-Gateway®). This 
plasmid makes use of the pLYS1U plasmid backbone (Matsuyama et al., 2008) and has the 
following advantages compared to pIY01: 
1. Constitutive, stable protein expression, provided by the Padh15 promoter cloned from plasmid 
pRAD15 (gift from Y. Watanabe). A comparison of the relative expression levels of this 
promoter with an nmt41 promoter can be found in Figure 4.1B);  
2. An artificial NLS derived from SV40; 
3. Integration into the S. pombe genome at the LYS1 locus, thus freeing up the LEU1 locus for 
the integration of another tethering construct. This allows for the combined tethering of 
multiple checkpoint components.  
A detailed description of re-engineered tethering construct, pIY03, can be found in Chapter 2. 
Once spc71-666-9TE was cloned into pIY03 by Gateway®-mediated recombination, testing showed 
that unlike previous attempts using pIY01, the resulting fusion protein could be successfully 
targeted to the ectopic array, forming bright RFP foci that do not co-localise with an Fta3-GFP 
kinetochore marker (Fig. 4.1C).  
4.5 Ectopically tethered Spc71-666-9TE is sufficient to recruit a stably associated form 
of Mad3 independently of Mph1 kinase 
Having created a functional Spc71-666-9TE tether, it was decided to first examine the effect that 
tethered Spc71-666-9TE would have on the cell-cycle dependent localisation of Bub1 and Bub3. 
Ectopically tethered Spc71-666-9TE was found to be sufficient to recruit both C-terminally GFP-
tagged Bub1 and Bub3 fusions (expressed under their own promoters) to the ectopic array in 
interphase cells (Fig. 4.2A). The activity of endogenous Mph1 kinase activity is not required for 
this ectopic recruitment, as mph1∆ spc71-666-9TE strains continue to exhibit co-localising Spc71-666-
9TE and Bub1-GFP/Bub3-GFP foci (Fig. 4.2B). This confirms previous findings that 
phosphorylation of the MELTs of Spc7 is the sole requirement for Bub3-Bub1 recruitment. 
Importantly, tethered Spc71-666-9TE was also found to be sufficient to ectopically recruit Mad3-
GFP in an mph1∆ background (Fig. 4.2B), showing that phosphorylation of Bub3 and Bub1 is not 
required for Mad3 recruitment to unattached kinetochores. However, although Mad3 can be 
recruited by ectopically tethered Spc71-666-9TE, this strain does not exhibit the morphological 
changes or the decrease in viability associated with prolonged activation of the spindle checkpoint 
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Fig. 4.1 – Spc71-666-9TE as an ectopic anchor for Bub3, Bub3 and Mad3. (A) Schematic of Spc71-666-9TE 
showing its nine phosphomimetic (E) substitutions and its truncation of the C-terminal kinetochore 
localisation domain. (B) Expression levels of the P
adh
 series of constutitive promoters compared to inducible 
intermediate strength P
nmt41
 promoter. (C) Ectopically tethered Spc7
1-666
-9TE does not localise to kinetochores. 
Tethered Spc7
1-666
-9TE-mCherry (red) does not co-localise with a GFP-tagged kinetochore marker, Fta3. Scale 

























































Fig. 4.2 – Ectopically tethered Spc71-666-9TE is sufficient to recruit Bub3, Bub1 and Mad3 independently of 
Mph1 kinase. (A) Tethered Spc7
1-666
-9TE (red) forms co-localising ectopic foci in interphase cells with 
Bub3-GFP, Bub1-GFP and Mad3-GFP (green). (B) Co-localisation between tethered Spc7
1-666
-9TE (red) and 





















(not shown), showing that the Spc71-666-9TE-Bub3-Bub1-Mad3 complex is not sufficient to 
activate the spindle checkpoint by itself.  
4.6 Ectopically tethered Spc71-666-9TE recruits Mad3 in a manner similar to that at 
unattached kinetochores 
The inability of ectopically tethered Spc71-666-9TE to generate a checkpoint arrest in spite of being 
capable of Mad3 recruitment suggested two possibilities: (i) co-localisation of at least one other 
spindle checkpoint component, perhaps Mad2, is required for active signalling, or (ii) the 
mechanism of Mad3 recruitment at the ectopic array, and hence its ability to form active MCC, is 
different from that at unattached kinetochores. For example, if ectopic recruitment of Mad3 
occurred via an unknown Bub1-independent pathway, perhaps by direct interaction with 
tethered Spc71-666-9TE, or if ectopically recruited Mad3 exhibited very different dynamics to that 
at unattached kinetochores, then it may well be dysfunctional in its ability to form MCC. To 
determine if this was the case, the dependencies between Mad3, Bub3 and Bub1 were first 
examined. Ectopic co-localisation of Mad3 with tethered Spc71-666-9TE was lost upon deletion of 
either Bub1 or Bub3 (Fig. 4.3), demonstrating that the ectopic recruitment of Mad3 occurs in the 
same Bub1-Bub3 dependent manner as at the kinetochores.  
 It was then decided to examine the dynamics of Bub1 and Mad3 at the ectopic array. Bub1 
and Mad3 exhibit very different dynamics at unattached kinetochores that are reflective of their 
different roles within the spindle checkpoint; whereas Bub1 is a stably associated component, 
hence its role as a scaffold protein, Mad3 cycles very dynamically on unattached kinetochores 
(Howell et al., 2004; Rischitor et al., 2007). Thus if ectopically recruited Bub1 and Mad3 exhibit 
very different dynamics to that at unattached kinetochores, then once again this may adversely 
affect their ability to generate active MCC at the tetO array. To determine if this was the case, 
FRAP was used to measure the dynamics of both Bub1-GFP and Mad3-GFP at the tetO array (Fig. 
4.4B). Analysis of the recovery profiles (for methodology see Section 2.3.3) showed that Bub1-
GFP exhibited a recovery of 44 ± 16 % (n = 10), and that this was achieved with a half-time of 18 
± 5 s (n = 10). In comparison, Mad3-GFP exhibited a higher level of recovery (60 ± 26 %, n = 7) 
and a shorter half-time (11 ± 5 s, n = 7), indicating that it is more dynamic that Bub1.  
 The relative dynamics of Bub1 and Mad3 measured at the ectopic array strongly correlate 
with those measured at S. pombe kinetochores in cells arrested using the cold-sensitive nda3 
mutation in combination with the anti-microtubule drug carbendazim (CBZ) (Bub1: recovery = 
39 % ± 16 %, half-time = 31 ± 3 s; Mad3: recovery = 82 % ± 9 %, half-time = 17 ± 4 s) (Fig. 4.4C) 
(Rischitor et al., 2007). These dynamics also correlate well with results from vertebrate FRAP 
studies of Bub1 and BUBR1. For Bub1, vertebrate dynamics vary somewhat depending on the 
experimental setup; one study using a cell line stably expressing YFP observed less than 20 % 
recovery (Shah et al., 2004), whilst a different study using a cell line transiently transfected N-
terminally tagged GFP-Bub1 obtained a recovery of 56 % with a corresponding half-time of ~30 s. 
In this context, S. pombe Bub1 dynamics at both unattached kinetochores and at the ectopic array 
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Fig. 4.3 – Ectopic recruitment of Mad3 by Spc71-666-9TE is Bub1 and Bub3 dependent. 




















Fig. 4.4 – Bub1 and Mad3 dynamics at ectopic array mirrors those at unattached kinetochores. 
(A) Schematic of Bub1 and Mad3 cycling on tethered Spc7
1-666
-9TE. (B) FRAP of Bub1 and Mad3 recruited by 
ectopically tethered Spc7
1-666
-9TE. Ectopic Mad3/Bub1-GFP foci formed by tethered Spc7
1-666
-9TE were then 
photobleached with a laser, and images captured at the specified intervals throughout the recovery period. 
The % fluorescence recovery and half-times shown are the mean of the indicated number of experiments. 
Error bars indicate standard deviation. The red line indicates the 50 % post-bleach recovery level. (C) 
Comparison of Bub1 and Mad3 cycling dynamics at the ectopic array and at unattached kinetochores. 
Kinetochore dynamics were measured by Karen May and are reproduced with permission from (Rischitor et 







Bub1-GFP FRAP Mad3-GFP FRAP
Array: t
K
 = 18 ± 5 s, recovery = 44 ± 16 %, n = 10 
Kinetochore: t
K
 = 31 ± 3 s, recovery = 39 ± 16 %, n = 9
Array: t
K
 = 11 ± 5 s, recovery = 60 ± 26 %, n = 7
Kinetochore: t
K























































 = 18 ± 5 s, recovery = 44 ± 16 %, n = 10 Array: t
K
























































would fall within the bounds of the current published vertebrate Bub1 data. More importantly, it 
is evident that S. pombe Mad3 dynamics agree with vertebrate BUBR1 data (Howell et al., 2004) 
showing that it is much more dynamic compared to Bub1.  
 From this FRAP data it was concluded that the ectopic tetO array is capable of re-
capitulating the different range of protein dynamics exhibited by different checkpoint 
components at unattached kinetochores, thus simultaneously underscoring the potential 
usefulness of the ectopic tethering assay in studying individual checkpoint protein interactions 
whilst increasing the likelihood that the ultimate aim of this work, namely the synthetic 
generation of functional MCC from the ectopic array, can be realised.  
4.7 The role of the Mad3 HIG motif in checkpoint signalling 
The above data demonstrated that the ectopic array was capable of not only recruiting checkpoint 
components, but also recruiting them in a physiological (similar to unattached kinetochores) 
manner. This greatly increased the confidence with which the system could be used to study 
unknown interactions in the checkpoint signalling pathway, and it was decided to adapt the 
system to examine a thus unstudied question, that of how a structural HIG motif on Mad3 affects 
its ability to localise to unattached kinetochores.  
 The homologues of S. pombe Bub1 and Mad3 contain a well-known and highly-conserved 
GIG motif (G137I138G139 in budding yeast Bub1) that is crucial for multiple key interactions in 
spindle checkpoint signalling. In budding yeast, a double mutation in the GIG motif of scMad3 
renders scMad3 unable to interact with scCdc20 (Hardwick et al., 2000), while in humans 
mutations in the GIG motifs of both hsBUB1 (Bolanos-Garcia et al., 2009) and hsBUBR1 
(Bolanos-Garcia et al., 2011) abolish their ability to bind hsKNL1. Note that, in all of these 
examples, expression of the GIG mutants remains at WT levels, ruling out simple mis-folding as 
the reason for the observed losses of interaction. Structural details of how mutations in the GIG 
motif may cause loss of interaction emerged from the analysis of a crystallised hsBUBR1 and 
hsKNL1 complex which revealed that double and triple mutations of the hsBUBR1 GIG motif are 
predicted to disrupt the TPR domains making up the hsKNL1 interaction surface (Bolanos-
Garcia et al., 2011).  
 These results point to an important, undefined role in the GIG-like H144I145G146 motif of S. 
pombe Mad3. To investigate this, two HIG point mutants were created (H144V and G146V) and 
their ability to localise to tethered Spc71-666-9TE was examined. The Mad3H144V-GFP mutant was 
found to be capable of localising to tethered Spc71-666-9TE, whilst the localisation of the 
Mad3G146V-GFP mutant is completely abolished (Fig. 4.5B), suggesting that it is unable to interact 
with Bub1 or Bub3, or both. Preliminary data (Fig. 4.5C) shows that Mad3G146V-GFP does not co-
immunoprecipitate with Bub3, suggesting that its failure to localise to tethered Spc71-666-9TE may 
be due to an inability to bind Bub3, although this may be an indirect effect caused by loss of Bub1 
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Fig. 4.5 – The role of the Mad3 HIG motif in checkpoint signalling. (A) Alignment of human and yeast Bub1 






 motif in spMad3 to the GIG motif. (B) The 
ability of Mad3
H144V
-GFP to localise to ectopically recruited Spc71-666-9TE is unimpaired compared to WT 
Mad3, whereas that of Mad3
G146V
 is completely abolished. (C) The ability of Mad3 to co-immunoprecipitate 
with Bub3 is impaired in the Mad3
G146V
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binding. To test this, current work in the lab is focussed on tethering the Mad3G146V mutant and 
assaying its ability to bind Bub1 and Bub3.  
4.8 Ectopically co-tethered Mad1 and Spc71-666-9TE insufficient to generate 
checkpoint arrest 
Having verified the dependencies and dynamics of Mad3 recruitment to the ectopic array, it 
became apparent that the inability of tethered Spc71-666-9TE to generate a checkpoint arrest was 
likely due to the absence of other checkpoint components at the ectopic array, with the most 
likely candidate being Mad2. As mentioned in Chapter 1 and Chapter 3, a myriad of works have 
over the years demonstrated in both mammalian and S. pombe systems that ectopic tethering of 
Mad1 or C-Mad2 to kinetochores by fusing them to outer kinetochore proteins (Ndc80, Mis12) is 
sufficient for constitutive spindle checkpoint activation (Kuijt et al., 2014; Maldonado and 
Kapoor, 2011). However, like the ectopic recruitment of Mad3 by Spc71-666-9TE demonstrated in 
this work, the ectopic tethering of Mad1 to chromosome arms (Maldonado and Kapoor, 2011) 
was by itself insufficient to activate the spindle checkpoint. 
 These findings made it plausible that co-localisation of Mad3 and C-Mad2 at the ectopic 
array through co-tethering of Spc71-666-9TE and Mad1 would be sufficient to generate a synthetic 
checkpoint arrest by forming MCC at the array. Surprisingly however, when this was tested cells 
continued to cycle normally without exhibiting signs of checkpoint arrest (data not shown), 
suggesting that co-recruited C-Mad2 and Mad3 on the ectopic array was unable to form active 
MCC.  
 This could be because:  
1. Although the tetO array is acting to bring Mad1 and Spc71-666-9TE molecules close 
together, it may be restricting the conformational freedom with which these proteins 
are able to interact with one another and thus inhibiting critical interactions that 
would occur at unattached kinetochores required for MCC formation; the same may 
be true of ectopically recruited C-Mad2 and Mad3; 
2. The fragment of Spc7 being tethered, Spc71-666-9TE, retains its N-terminal protein 
phosphatase (PP1Dis2) binding site and may therefore be suppressing any MCC being 
generated at the ectopic array; In mammalian cells, there is evidence suggesting that 
hsPP1 binding to KNL1 is inversely proportional to localised Aurora B activity (Liu et 
al., 2010), and thus the absence of Ark1 at the ectopic array may be producing a level 
of localised PP1Dis2 activity sufficient to overwhelm ectopic signalling; 
3. Another checkpoint component remains missing from the ectopic tether.  
If the absence of ectopic checkpoint assembly is indeed due to the absence of another checkpoint 
component, the likely candidate is Mph1 kinase. As described in Chapter 1, Mph1 has multiple 
checkpoint protein substrates, including Mad1, and its localisation to unattached kinetochores is 
crucial for activation of the spindle checkpoint. Indeed, tethering of Mph1 kinase to kinetochores 
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is sufficient for checkpoint dependent cell arrest (Heinrich et al., 2012; Ito et al., 2012). Thus, the 
subsequent chapter will explore whether tethered Mph1 kinase will be sufficient for ectopic 
signalling.  
4.9 Summary and perspectives 
This chapter achieved two broad goals. First, it demonstrated that the simple tethering system 
used to examine Mad1-Mad2 interaction in Chapter 2 could be improved to faithfully re-create a 
much more complex set of checkpoint interactions, namely that between Bub3, Bub1 and Mad3. 
This makes the system a useful in vivo assay for examining checkpoint protein interactions 
beyond the ones presented here: ongoing work in the lab include using the tethering assay for 
investigate Bub1 dimerisation and the effect of point mutations in Bub1 on its ability to bind 
Mad3. Second, the work presented here represents a step forward in the generation of ectopic 
MCC; the closeness with which the behaviour of ectopically recruited components resembles that 
at the kinetochores increases the likelihood that, with the addition of other checkpoint 
components such as Mph1 kinase, complete MCC assembly can be achieved at the ectopic site. 




Co-localisation of Spc71-666-9TE and Mph1Δ1-302 kinase is 
sufficient to ectopically activate the spindle checkpoint 
away from kinetochores 
5.1 Introduction 
The previous chapter described how, contrary to expectations, the co-targeting of key MCC 
components Mad2 and Mad3 to the ectopic array was insufficient to generate a synthetic 
checkpoint arrest. This chapter examines whether this is due to the absence of key 
phosphorylation events at the ectopic array due to a lack of localised checkpoint kinase activity. 
Specifically, it will determine whether the co-targeting of Mph1 kinase and Spc71-666-9TE to the 
ectopic array is sufficient to generate a synthetic checkpoint arrest, possibly through a 
phosphorylation-dependent interaction between the Spc71-666-9TE-Bub3-Bub1-Mad3 and Mad1-
C-Mad2 scaffolds.  
5.2 Co-tethered Mph1Δ1-303 and Spc71-666-9TE are sufficient to generate a tetO array 
dependent metaphase arrest 
As detailed in Chapter 1, the checkpoint kinase Mps1/Mph1 is the most upstream component in 
the spindle checkpoint signalling pathway alongside Ark1 (Heinrich et al., 2012). Importantly, 
Mph1/Mps1 targets the basal checkpoint scaffold components such as Spc7, Bub3, Bub1 and 
Mad1, and in S. cerevisiae the co-localisation and activity of Mps1 is essential for both the 
Spc105-mediated recruitment of Bub1, as well the subsequent ability of Bub1 to recruit Mad1 and 
form a functional signalling scaffold (London and Biggins, 2014a). Whether this model of 
checkpoint scaffold assembly extends to S. pombe remains unknown, but if so then tethered 
Mph1 at the ectopic array would likely be essential for the ability of Spc71-666-9TE to generate a 
synthetic checkpoint arrest.  
 To test this directly, it was decided to co-tether a fragment of Mph1 to the ectopic array 
together with Spc71-666-9TE. It was determined that the fragment of Mph1 to be tethered should 
have the following features: 
1. Inducible expression. Should co-targeting of Mph1 and Spc71-666-9TE be sufficient to 
activate the checkpoint, cells may eventually leak through the constitutive metaphase 
arrest and septate without having satisfied the checkpoint. This would produce the ‘cut’ 
phenotype that is characteristic of fission yeast: undivided nuclei are either cleaved by 
septa formation or are asymmetrically distributed to the daughter cells. In either case, 
cell death shortly follows. To prevent this from making the combined Mph1/Spc71-666-
9TE strain inviable, Mph1 expression must be inducible.  
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2. Expression levels similar to WT. Overexpression of Mph1 results in constitutive spindle 
checkpoint activation, possibly through the hyper-phosphorylation of Mad1, and this 
drives Mad1 to kinetochores (Chapter 1). To minimise the possibility of checkpoint 
activation by Mph1 overexpression rather than its localised effects on tethered Spc71-666-
9TE, the levels of tether-able Mph1 should be kept as close to endogenous as possible.  
3. Kinetochore localisation deficient. To simplify the interpretation of Mph1 tethering 
experiments, it is advantageous to remove the ability of tether-able Mph1 to localise to 
endogenous kinetochores; this will allow any effects on checkpoint signalling to 
attributable solely to tethered Mph1 at the ectopic site (in the absence of endogenous 
Mph1).  
After initial experimentation with a number of N-terminal Mph1 truncations and expression 
constructs failed to produce a mutant with these features (data not shown), it was decided to 
incorporate an Mph1Δ1-302 fragment into a modified nmt81-driven tethering vector (pIY02). This 
fragment of Mph1 had been characterised by Heinrich and colleagues as being deficient in 
kinetochore localisation but capable of catalysing checkpoint activation when forcibly localised to 
kinetochores (Heinrich et al., 2012). Immunoblotting of Mph1Δ1-302 expressed from pIY02 showed 
that the abundance of rTetR-mph1Δ1-302 was comparable to wild-type Mph1 (Fig. 5.1C). 
Importantly, this level of expression is significantly below that which is required for checkpoint 
arrest (Fig. 5.1C, Pnmt41-Mph1, lanes 12-13).  
 It was then tested whether co-tethering Mph1Δ1-302 with Spc71-666-9TE would be sufficient to 
activate the spindle checkpoint. To do this a strain that combined constitutive expressed rTetR-
mCherry-Spc71-666-9TE and inducibly expressed rTetR-Mph1Δ1-302 with a Mad2-GFP reporter was 
analysed as described in Fig. 5.1B. In control cells (rtTA-mph1Δ1-302 OFF), rTetR-mCherry-Spc71-
666-9TE could be observed as singular red foci at the ectopic array, whilst Mad2-GFP forms a 
green ring along the nuclear periphery (Fig. 5.2A). By contrast, in cells where rTetR-Mph1Δ1-302 
expression had been induced for 14 hours, Mad2-GFP had de-localised from the nuclear 
periphery and could be observed forming two distinct foci at opposite poles of the nucleus (Fig. 
5.2A). rTetR-mCherry-Spc71-666-9TE did not co-localise with these Mad2-GFP foci. The 
proportion of cells exhibiting this phenotype increased in later time points. Concomitant with 
Mad2-GFP foci formation, cells began to display morphological changes consistent with the ‘cut’ 
phenotype, namely the formation of septa through undivided nuclei and the appearance of 
aneuploid daughter cells (Fig. 5.2A).  
 These observations are indicative of an initial metaphase arrest followed by septation. In 
both S. pombe (Saitoh et al., 2005) and vertebrates (Howell et al., 2000, 2001), Mad2 migrates 
from the nuclear periphery to the SPBs in late metaphase, forming two distinct foci consistent 
with that described above. These foci disappear in late anaphase, again consistent with the 
observations above when cells begin to leak through the prolonged metaphase arrest with ‘cut’ 
characteristics (Fig. 5.2A). These phenotypes are not observed in a strain in which only rTetR-
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Fig. 5.1 – Ectopic tethering of a Mph1 fragment that is unable to localise to kinetochores. (A) Kinetochore 
localisation of Mph1 is dependent on its N-terminus. Schematic of spMph1 kinase showing the Mph1
∆1-302
 
truncation used in (Heinrich et al., 2012) to identify the N-terminal kinetochore localisation domain. (B) 
Schematic of inducible Mph1
∆1-302
 time-course experiment. Cells are loaded with thiamine for 8 hours before 
being split into two parallel cultures, one with Mph1
∆1-302
 expression induced and the other with Mph1
∆1-302
 




) similar to WT Mph1 levels. 
Cells were grown as shown in (B) and harvested after 16 hours of growth in the absence of thiamine. Note the 
high degree of Mph1 overexpression required for checkpoint arrest (P
nmt41
-Mph1, lanes 12-13) as described in 




















































Fig. 5.2 – Co-tethered Mph1





-9TE induces cellular changes consistent with sustained metaphase 
arrest. Cells were grown as described in Fig. 5.1B and representatives samples taken after 14 and 20 hours of 
rtTA-mph1
∆1-302
 induction are shown. (B) Schematic of morphological changes shown in (A). (From left to 
right): unarrested interphase cell with Mad2-GFP  at the nuclear periphery and rTetR-mCherry-Spc7
1-666
-9TE 
localised at the ectopic array; arrested cell showing Mad2-GFP at SPBs, a sign of late metaphase/early 
anaphase, and rTetR-mCherry-Spc7
1-666
-9TE signal separation as sister chromatids come under tension; 
prolonged metaphase arrest leads to septation without nuclear division (’cut’), resulting in either two 
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Mph1Δ1-302 is tethered (Fig. 5.3A), indicating that phosphorylation of Spc71-666-9TE-recruited 
checkpoint components (Bub3, Bub1 and Mad3) by Mph1Δ1-302  is required for this metaphase 
arrest. It is possible that this metaphase arrest requires phosphorylation of other checkpoint 
components recruited by the Spc71-666-9TE-Bub3-Bub1-Mad3 complex. These phenotypes are 
likewise not observed when rTetR-mCherry-Spc71-666-9TE and rTetR-Mph1Δ1-302 are expressed in 
the absence of the tetO array (Fig. 5.2B), demonstrating that the enrichment of Spc71-666-9TE and 
Mph1Δ1-302 at a single location is crucial for the generation of the observed metaphase arrest.  
 To confirm that the Mad2-GFP foci observed were truly localised at the SPBs rather than at 
kinetochores that have been pulled close to the SPBs by the spindle, rTetR-Mph1Δ1-302 was co-
tethered with rTetR-mCherry-Spc71-666-9TE in strains expressing an SPB marker, Pcp1-mCherry, 
or a kinetochore marker, Fta3-tdT. Pcp1 (Pole target of Calmodulin in Pombe), a pericentrin-like 
protein, serves as a SPB marker by virtue of being a constitutive component of SPBs (Flory et al., 
2002). In metaphase arrested (rtTA-mph1Δ1-302 ON) cells, Mad2-GFP co-localisation was observed 
with Pcp1-mCherry (Fig. 5.4A), but not Fta3-tdT (Fig. 5.4B), confirming the SPB localisation of 
the Mad2-GFP foci above. In addition, the absence of Mad2-GFP at kinetochores serves as 
further evidence that this metaphase arrest is distinct from that observed upon simple Mph1 
overexpression, in which Mad1-C-Mad2 can be observed localising to kinetochores (Ito et al., 
2012).  
5.3 Spc71-666-9TE and Mph1Δ1-302 induced metaphase arrest is spindle checkpoint-
dependent 
To determine if the tethering-induced metaphase arrest was spindle checkpoint-dependent, 
rTetR-Mph1Δ1-302 was co-tethered with rTetR-mCherry-Spc71-666-9TE in strains lacking Mad1. 
This strain failed to arrest upon induction of rtTA-Mph1Δ1-302 (Fig. 5.5A). Furthermore, 
preliminary work shows that the same phenotype is observed in a strain lacking Mad3 (not 
shown). Together, these results suggest that (i) the tethering-induced metaphase arrest is 
mediated by the spindle checkpoint, and (ii) the arrest requires a combination of the Mad1-C-
Mad2 and Spc71-666-9TE-Bub3-Bub1-Mad3 scaffolds. A key question is where these two 
checkpoint scaffolds interact to generate the checkpoint signal. One possible model is that one or 
more constituents of the tethered Spc71-666-9TE-Bub3-Bub1-Mad3 scaffold is phosphorylated by 
co-tethered Mph1Δ1-302, thus initiating a checkpoint signal that is then propagated away from the 
ectopic array.   
 To test this model, Mad3-GFP localisation was followed in a strain in which rTetR-
mCherry-Spc71-666-9TE and rTetR-Mph1Δ1-302 were co-tethered. In control cells (rtTA-Mph1Δ1-302 
OFF), Mad3-GFP can be observed as a single focus that co-localises with tethered rTetR-
mCherry-Spc71-666-9TE (Fig. 5.5B). However, 14 hours after rtTA-mph1Δ1-302 induction, Mad3-
GFP can be observed forming two additional foci at the SPBs, suggesting that Mad3 had migrated 
from the ectopic array to the SPBs. Consistent with this, the intensity of Mad3-GFP foci 
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Fig. 5.3 – Tethering induced metaphase arrest requires both tethered Mph1
∆1-302 and Spc71-666-9TE. (A) 
Tethered Mph1
∆1-302
 is insufficient to induce metaphase arrest. Cells were grown as described in Fig. 5.1B and 
representative samples taken after 20 hours of rtTA-mph1
∆1-302





 are insufficient to induce metaphase arrest when de-localised from ectopic tether site. Cells were 
grown as described in Fig. 5.1B and representative samples taken after 20 hours of rtTA-mph1
∆1-302
 induction 
are shown. Note that in the absence of the tetO array, rTetR-mCherry-Spc7
1-666
-9TE can no longer be 
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Fig. 5.4 – Mad2 localises to SPBs during tethering induced metaphase arrest. (A) Mad2-GFP co-localises 
with SPB marker Pcp1-mCherry during tethering induced metaphase arrest. Cells were grown as described in 
Fig. 5.1B and representative samples taken after 20 hours of rtTA-mph1
∆1-302
 induction are shown. (B) 
Mad2-GFP does not co-localise with KT marker fta3-tdT during tethering induced metaphase arrest. Cells 
were grown as described in Fig. 5.1B and representative samples taken after 16 hours of rtTA-mph1
∆1-302
 
induction are shown. Note that in interphasic (non-arrested) cells, clustering of kinetochores causes the 
formation of singular fta3-tdT foci. In contrast, cells leaking through prolonged metaphase arrest exhibit 
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Fig. 5.5 – Tethering induced metaphase arrest is spindle checkpoint dependent. (A) Tethering-induced 
metaphase arrest is dependent on Mad1. Cells were grown as described in Fig. 5.1B and representative 
samples taken after 20 hours of rtTA-mph1
∆1-302
 induction are shown. Deletion of checkpoint component Mad1 
rescues tethering-induced metaphase arrest. (B) Mad3 migrates from ectopic tether site to SPBs during 
tethering-induced metaphase arrest. Cells were grown as described in Fig. 5.1B and representative samples 
taken after 16 hours of rtTA-mph1
∆1-302
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remaining at the ectopic array is diminished compared to that in cells where Mad3-GFP had not 
yet begun migrating to the SPBs. Together, these observations are supportive of the above model 
of checkpoint initiation at the ectopic array followed by propagation elsewhere in the 
nucleoplasm.  
5.4 Summary and perspectives 
5.4.1 Concentration of checkpoint components key for signalling activation 
As described in Chapter 3, various studies have tested whether individual spindle checkpoint 
components tethered at non-centromeric locations are sufficient to activate the checkpoint. 
Although unsuccessful in checkpoint activation, these studies have paved the way to addressing 
what is arguably the most central question of spindle checkpoint signalling: do the kinetochores 
serve only to enrich for checkpoint components, or do they possess other features required for 
checkpoint activation? The results presented in this chapter argue in favour of the former. 
Together with Ark1/Aurora B, Spc7/KNL1 and Mph1/Mps1 are both recognised as the most 
upstream components of the checkpoint signalling pathway. By demonstrating that the combined 
targeting of Spc7 and Mph1 fragments is sufficient to activate the checkpoint away from the 
kinetochores, the results here emphasise the importance of enrichment and post-translational 
modification for checkpoint activation. These are central concepts common to all signalling 
pathways both biological and synthetic, and by underscoring their importance here these results 
serve as a reminder of why the study of the spindle checkpoint is important not only for its own 
sake, but also for furthering our understanding of signalling pathways in general.   
5.4.2 Mapping the synthetic signalling pathway 
Nevertheless, important questions about the tethering induced checkpoint signal remain. First 
and foremost, the signalling pathway remains incomplete. When cells enter a normal checkpoint 
arrest, Mad2 moves from the nuclear periphery first to the kinetochores in metaphase and from 
there to the SPBs in late metaphase/early anaphase. During a tethering-induced checkpoint arrest, 
however, Mad2 disappears from the nuclear periphery and later re-appears at the SPBs without 
ever appearing at the ectopic array. This stands in contrast to the localisation pattern of Mad3, 
which forms clear foci at the ectopic array during interphase before re-locating to the SPBs 
during a tethering-induced arrest. These observations raise two important questions. First, where 
is soluble O-Mad2 activated to form C-Mad2 that is then capable of binding Slp1? In a normal 
checkpoint arrest this occurs via Mad1 binding at the unattached kinetochores, but as noted 
above Mad2 does not appear to co-localise with kinetochore markers (Fig. 5.4B), and nor does it 
seem to co-localise with the ectopic array. Second, once the Mad2-C-Slp1 complex is formed, 
where does it interact with Mad3 to form MCC? 
 There are two possible models that address these questions. First, Mad2 may be activated via 
transient Mad1 binding to the tethered Spc71-666-9TE-Bub3-Bub1-Mad3 complex, similar to the 
model in S. cerevisiae in which Mps1-phosphorylated Bub1 forms a stable complex with Mad1 
(London and Biggins, 2014a). The transient nature of this interaction would then explain why it 
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has thus far escaped detection by snapshot imaging. If so, a switch to time-lapse imaging 
(currently ongoing) will provide the temporal resolution required to resolve this issue. However, 
such a transient interaction between Mad2-C-Mad1 and the tethered Spc7 complex would run 
contrary to the canonical Mad2-template model, which would predict that a pool of stably 
associated Mad1-C-Mad2 is required at the ectopic array before it could potentially catalyse 
Mad2-C-Slp1Cdc20 formation. It is important to note here that, at least in S. pombe, endogenous 
Mad1 levels can be reduced by up to 70 % without significant impairment of the checkpoint 
response (Heinrich et al., 2013). This means that only a relatively small pool of Mad1-C-Mad2 
complexes would need to present at the ectopic array in order to support Mad2 activation and 
checkpoint function. As mentioned above, improvements to imaging will likely be required 
before this possibility can be ruled out. Immuno-fluorescence imaging using anti-Mad1 and/or 
anti-Mad2 antibodies may also prove useful in determining the localisation of these upstream 
checkpoint components during the early stages of synthetic checkpoint arrest. 
 An alternative model is that Mad1 in S. pombe does not form a stable association with the 
Spc7-Bub3-Bub1-Mad3 complex. Instead, Mad2 can be activated away from the kinetochores, 
where it can then interact with nucleoplasmic Mad3 and Slp1Cdc20 to form MCC. This model is 
consistent with several lines of evidence. First, it has long been known that checkpoint 
components are capable of assembling MCC away from the unattached kinetochores where they 
are usually enriched. When the majority of checkpoint components (including Mad1 and Mad2) 
are evicted from S. pombe kinetochores by deletion of bub3 (Vanoosthuyse et al., 2009; 
Windecker et al., 2009), or from human-derived kinetochores by Hec1 knock-down (Martin-
Lluesma et al., 2002), the checkpoint remains surprisingly functional. These studies imply that 
Mad2 and Mad3 is capable of being activated at location(s) other than unattached kinetochores.  
 As described previously in Chapter 1, the NPC is a prime candidate for this location. In 
human-derived cells, Mad1 interaction with the nuclear basket protein Tpr (S. pombe: Nup211; S. 
cerevisiae: Mlp1) during interphase enables it to activate Mad2 and drive MCC formation in the 
same manner as Mad1-kinetochore interaction (Rodriguez-Bravo et al., 2014). How BUBR1 and 
Cdc20 interact with C-Mad2 and form MCC in this NPC-driven signalling pathway is unclear, 
but given that the KNL1-Bub3-Bub1-BUBR1 complex has not been observed to localise to NPCs, 
these interactions will almost certainly be different from kinetochore-driven signalling. 
Specifically, it suggests that Mad2 and BUBR1/Mad3 co-localisation is not a requirement for 
MCC generation and that, as may be the case for the tethering-induced signalling described 
above, NPC-activated C-Mad2 is capable of nucleoplasmic interaction with Cdc20/Slp1 and 
Mad3 to form MCC.  
 The data presented thus far is consistent with the following model for tethering-induced 
checkpoint signalling. Tethered Spc71-666-9TE recruits the Bub3-Bub1 complex, which in turn 
promotes the recruitment of dynamically cycling Mad3. Phosphorylation of these checkpoint 
components by tethered Mph1Δ1-302 then enables Mad3 to efficiently bind Cdc20Slp1 and Mad2, 
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either diffusely in the nucleoplasm or possibly at or near the SPBs (see following section). This 
forms a pool of MCC generated independently of kinetochores.  
5.4.3 The role of the SPBs in tethering-induced checkpoint signalling 
In order to fully explore the above model, ongoing work aims to track the localisation of Slp1-
GFP during a tethering-induced arrest: would Slp1-GFP localise to the SPBs in late metaphase, as 
with Mad2 and Mad3 described above? If so, what is the signalling function of this localisation, if 
any? The role of SPBs in spindle checkpoint signalling is poorly understood. Although Mad1 and 
Mad2 have been observed migrating from kinetochores to SPBs along spindle fibres in both S. 
pombe (Saitoh et al., 2005) and higher eukaryotes (Défachelles et al., 2015), this dynein-
dependent migration is thought to be part of a silencing mechanism unique to higher eukaryotes 
(Chapter 1), and its role in yeast remains unknown. Thus even if Slp1-GFP was observed to co-
localise with Mad2 and Mad3 at the SPBs during a synthetic arrest, this does not necessarily 
imply that the SPBs act as a kinetochore-independent site of MCC assembly.  
 To determine if the accumulation of Mad2 and Mad3 at the SPBs described in this chapter 
serves an active role in tethering-induced signalling or is a merely a passive by-product of 
metaphase arrest, current work is examining if disrupting the spindle transport apparatus upon 
which Mad2 depends for its SPB localisation will affect the ability of cells to arrest. Specifically, 
the spindles will be depolymerised through use of the nda3-KM311 mutation, whilst deletion of 
dynein will abolish motor-dependent spindle transport.  
 Furthermore, determining the location of APC/C will likely provide useful information on 
the role of SPBs in signalling; if the SPBs truly function as a site of MCC assembly in a tethering-
induced checkpoint arrest, then it may also serve as a site of MCC-APC/C interaction. The 
APC/C has been documented to localise to unattached kinetochores in a checkpoint-dependent 
manner (Gillett et al., 2004), and although the function of this localisation remains unclear, 
speculation points to MCC-driven APC/C inhibition at the unattached kinetochores. Thus if 
APC/C interaction was observed at the SPBs, this would provide at least limited evidence for the 






As stated in Chapter 1, the main goal of this work was to determine whether the role of the 
kinetochores within the spindle checkpoint signalling pathway is limited to concentrating 
checkpoint components. By using an artificial, non-kinetochore binding platform to concentrate 
selected checkpoint components, and then by demonstrating that this can generate a checkpoint 
signal, this work suggests that the kinetochores serve as a ‘component concentrator’ in the 
context of spindle checkpoint signalling.  
 As described in the preceding chapter, other groups have succeeded in either generating a 
checkpoint signal through tethering signalling components to the kinetochore, or in tethering 
signalling components to non-kinetochores locations without a resultant checkpoint, but not 
both. Thus these approaches have left unanswered the central question of the role of the 
kinetochores. This work represents the first time that a spindle checkpoint signal capable of 
robust metaphase arrest has been generated by concentrating checkpoint components at a 
location other than the kinetochores, and it is here that the novelty and the value of this work lies.  
 Further work is needed to realise the full potential of the tetO-based ‘checkpoint generator’ 
developed in this work. In particular, the tetO-based ectopic checkpoint generator has three 
drawbacks in its current configuration that limits its potential. First, sometimes tetR-fused 
molecules localise to the tetO array in absence of anhydrotetracycline; this ‘leakiness’ in the 
system limits the inducibility of checkpoint protein tethering and forces the user to use the 
inducible expression of tether-able Mph1 as a means of controlling checkpoint signal generation.  
 Second, there is currently no way to regulate the number and stoichiometry of checkpoint 
proteins being targeted to the tetO array, viz. for every molecule of Spc7 recruited to the array, 
how many molecules of Mph1 are recruited? How many molecules of Spc7 and Mph1 are 
typically present at the array? The ability to measure, and in future experimentally manipulate 
these parameters can be expected to yield data useful for producing a more quantitative model of 
ectopic checkpoint signalling. This in turn will be informative for the building of even more 
minimalistic ectopic ‘checkpoint generators’. 
 The third and final drawback is that it is currently difficult to obtain a comprehensive list of 
downstream checkpoint components that are being recruited by ectopically tethered Spc7 and 
Mph1, e.g. is Slp1 recruited to the array? Related to this point, it is unknown what PTMs may be 
associated with the checkpoint components that are recruited to the array.  
 To overcome many of these technical limitations the current tetO array will be replaced by a 
mixed tetO/lacO array that will be synthesised in a 1:1 ratio on an artificial chromosome arm. 
Under this scheme, one checkpoint component (e.g. Spc7) will be targeted to the array by fusion 
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with lacI, while a second component will be targeted by fusion with tetR (e.g. Mph1). This mixed 
array will thus be able to ensure that ectopically recruited checkpoint components are present in a 
strict 1:1 stoichiometry. Furthermore, it is envisaged that the new array will be synthesised with 
flanking loxP sites that, after checkpoint components are recruited to the array, will enable the 
entire array to be excised through the introduction of Cre recombinase. The excised array with 
bound checkpoint components can then be analysed through mass spectrometry to reveal the 
identity of the bound components. Building such a long stretch of repetitive sequence (mixed 
tetO and lacO repeats) using conventional cloning will be an extremely difficult if not impossible 
task, and thus the synthesis of this mixed array will be outsourced to a third-party, such as the 
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